




Title of Document: EVALUATING THE EFFICACY OF 
BEHAVIORAL ACTIVATION AMONG 
SPANISH SPEAKING LATINOS   
  
 Anahi Collado, Doctor of Philosophy, 2014 
  





Major depressive disorder (MDD) is highly prevalent among U.S. Spanish-
speaking Latinos. Although MDD is very treatable, the lack of empirically-supported 
treatments precludes this population’s access to quality mental health care. Following 
the promising results of a small open-label pilot study in which we tested the efficacy of 
Behavioral Activation Treatment for Depression (BATD) in a sample Latinos with 
Spanish-speaking preference, we conducted a randomized control trial (RCT; N = 46) 
that compared BATD (N = 23) to supportive counseling (N = 23) across various 
domains, including depression, BATD proposed mechanisms (activity level and 
environmental reward), and non-specific psychotherapy factors. Results indicated that 
relative to SC, BATD led to greater decreases in depressive symptoms over time (p = 
0.04) and greater MDD remission at the end of treatment and at the one-month follow-
up (p = 0.01). Activity level (p = 0.01) and environmental reward (p = 0.05) showed 
greater increases over time among participants who received BATD compared to SC. 
Further, proposed BATD mechanisms of change did not correspond over time with 
depressive symptomatology. Treatment adherence, therapeutic alliance, and treatment 
 
 
satisfaction did not differ between the groups (ps > 0.17). The one-month follow-up 
suggested sustained clinical gains across therapies. The current study adds to a limited 
treatment research literature and suggests that BATD, a time-limited and straightforward 
intervention, is efficacious in reducing depression and increasing activity level and 
environmental reward in this important, yet underserved population of the U.S. The 
current study sets the stage for a larger RCT to examine BATD against an empirically-
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Chapter 1: Introduction 
1.1 Major Depressive Disorder  
 
Major Depressive Disorder (MDD) is a highly prevalent affective disturbance 
across race and ethnicity (Kessler, Chiu, Demler, Walters, 2005). MDD is characterized 
by episodes of depressed mood and/or loss of interest in activities for at least two weeks 
or more (DSM IV TR, 2000). The core MDD symptoms consist of any combination of 
five criteria, including shifts in eating behaviors, weight or sleep, difficulty 
concentrating, decreased energy and changes in body movement activity, feelings of 
worthlessness or guilt, and recurrent suicidal ideation (DSM IV TR, 2000: 356). Suicide 
attempts or completions are the most severe consequence of a depressive episode (DSM 
IV TR, 2000). MDD has been estimated to be the primary cause of disability worldwide 
(Murray & Lopez, 1997), impairing physical, social, and economic life areas 
(Ciechanowski, Katon & Russo, 2000; Lustman, Clouse & Freedland, 1998). 
1.2 Rates of Depression among Latinos 
 
Although depression is a highly treatable condition, disparities in mental health 
treatment have been implicated in preventing low-income, ethnic, and immigrant 
populations from accessing effective interventions (Blanco et al, 2007; Brown, Ahmed, 
Gray, & Milburn, 1995). Specifically, Latinos represent 16.6% of the US population, are 
the fastest growing minority group, (US Census Bureau, 2010), yet are less likely to 
utilize mental health services (Hu, Snowden, Jerrell & Nguyen, 1991; Wells, Klap, 
Koike, & Sherbourne, 2001). A report by Blanco and colleagues (2007) concluded that 
between 1993 and 2002, mental health-related visits decreased from 12.2% to 11.7% 
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among Latinos while it increased from 13.1% to 15.7% among non-Latinos. One 
plausible interpretation of these findings could be that during this decade the occurrence 
of MDD among Latinos was lower than for other groups, but such an explanation is 
contradicted by research suggesting that mental health morbidity is equivalent for 
Latinos. In fact, in the United States, the lifetime prevalence of MDD has been reported 
between 6-17% for the general population and between 3-18% among Latinos residing 
in the United States (Mendelson, Rehkopf & Kubzansky, 2008; Kessler et al., 2003; 
Vega et al., 1998). With the exception of a small number of studies suggesting that 
Latinos in the United States are twice as likely to experience depression relative to non-
Hispanic White Americans (e.g., Alegria, Canino, Stinson & Grant, 2006; Oquendo et 
al., 2001), the majority of the literature indicates that there are no significant differences 
in the prevalence of the disorder between these groups (Dunlop et al., 2003; Kessler et 
al., 1994; Kessler et al., 2003).  
However, when examining the occurrence of MDD within specific Latino 
subgroups, higher prevalence of the disorder has been observed in Latinas relative to 
White and African American women (Bromberger, Harlow, Avis, Kravitz, & Cordal, 
2004; Shatell, Smith, Colwell & Villalba 2008) and in the last two decades, significant 
increases in the prevalence of suicide attempts among adult Latino males have been 
reported (Baca-Garcia et al., 2010). In a sample of 6,321 White non-Hispanics, English-
speaking Latinos, and Spanish-speaking Latinos, Folsom et al. (2007) found the highest 
prevalence of MDD in the latter group. In earlier research, Muñoz and colleagues (1993) 
also found rates of current major depression to be as high as 25% in Spanish-speaking 
primary care patients, which is higher relative to the general population (Kessler et al., 
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2003). Altogether, these findings highlight the pressing need for depression treatment 
delivery in this group. 
1.3 Depression Treatment Disparities among Latinos 
 
As mentioned previously, treatment-related disparities often prevent proper care 
for minority groups (e.g., Department of Health & Human Services [DHHS], 2001). 
Psychosocial treatments for depression have been found to benefit Latinos; nevertheless, 
Latinos exhibit lower utilization of mental health services in comparison to other ethnic 
minorities and non-Hispanic Whites (Wells, Klap, Koike & Sherbourne, 2001), specially 
for Latinos who report a Spanish language preference (Keyes et al., 2012). Consistent 
with these disparities, a study of the quality of care for depression and anxiety disorders 
indicated that only 24% of Latinos received appropriate mental health care, compared to 
34% of non-Hispanic White Americans (Young, Klap, Sherbourne & Wells, 2001). In 
the 1990s, it was reported that fewer than 1 in 5 Latinos born in the United States who 
suffered from mental health disorders sought help from general practitioners, decreasing 
to 1 in 11 who contact specialized mental health services (DHHS, 2001). These data are 
more indicative of poor utilization of services when specifically examining Latino 
immigrants, in which less than 1 in 10 individuals sought these services from general 
health practitioners and 1 in 20 from mental health professionals (Hough et al., 1987; 
Vega et al., 1999).  
These striking statistics are further exacerbated by reports indicating that not 
only is there less access to mental health services for this group and that services are 
often delayed when available (Wells, Klap, Koike & Sherbourne, 2001), but that when 
service is actually delivered, it is substandard; Latinos who seek help for depression in 
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primary care settings are less likely to receive evidence-based depression care than non-
Hispanic White patients (Young, Klap, Sherbourne & Wells, 2001). Subsequent research 
has indicated that Hispanics are more likely than non-Hispanic White clients to have 
persistent and recurring psychiatric disorders, suggesting inadequate treatment practices 
for this group (Breslau, Kendler, Su, et al., 2005). Common reasons postulated for these 
treatment inequalities are language barriers, the inability to afford the cost of services, 
and lack of culturally-congruent treatment services (DHHS, 2001).  
1.4 Spanish Language Preferences as a Deterrent to Receiving Depression Treatment 
 
In a population survey that examined the prevalence of psychiatric disorders in 
3,012 respondents of Mexican origin, 33% of U.S. born adults indicated a language 
preference towards Spanish, rising to 64% and 75% for immigrant males and females, 
respectively (Vega et al., 1998). Another population survey showed that U.S. Latinos 
who preferred speaking in Spanish utilized mental health services at much lower rates 
than those who preferred speaking in English, controlling for controlling for ethnic 
subgroup, disorder severity, time spent in the US, and economic and practical barriers 
(Keyes et al., 2012).  More recently, Aponte-Rivera and colleagues (2014) showed that 
Spanish-speaking Latinos had greater depression severity and reported a greater number 
of suicide attempts relative to English-speaking Latinos.  
The importance of language is highlighted by reports suggesting that as many as 
30% of Latinos report difficulty in communicating with health care providers in English 
(Vega, 2007). Moreover, as a result of English literacy requirement exclusions, Latinos 
have historically been highly underrepresented in both clinical and research samples 
(Miranda et al., 1996; Wells et al., 2001), leading to a paucity of mental health treatment 
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research within this population (Delgado et al., 2006; Schraufnagel, Wagner, Miranda & 
Roy-Byrne, 2006). Thus, it is not surprising that findings suggest higher rates of 
depression among Spanish-speaking Latinos relative to other ethnic groups given 
research indicating that language barriers promote Latinos’ social isolation and limited 
access to health care, resulting in distress, low perceived self-efficacy, and higher 
depression prevalence (Ding & Hargraves, 2009; Woodward, Dwinell & Arons, 1992). 
Addressing language barriers is crucial given findings indicating that when disparities in 
both language and culture are reduced, Latinos’ utilization of mental health services is 
similar to that of the general population (Alegria, Mulvaney-Day, Woo, et al., 2007; 
Cabassa et al., 2006).  
Given the indication that a language barrier may be contributing to treatment 
disparities for an important subset of Latinos, research has examined the importance of 
providing therapy in the clients’ native or preferred language. A meta-analysis suggested 
that interventions conducted in clients’ native language (if other than English) were 
twice as effective as interventions conducted in English (Griner & Smith, 2006). This 
finding is consistent with research suggesting the psychological counseling should be 
conducted in clients’ preferred or native language, which enhances their engagement in 
the therapeutic process and decreases the likelihood of being distracted by non-therapy 
related concerns, such as difficulty with pronunciation (Dwight-Johnson, Lagomasino, 
Aisenberg & Hay, 2004). Clearly, delivering efficacious treatment in clients’ preferred 
language should be an important consideration for addressing the low retention rates in 
this group.  
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1.5 Stigma-Related Fears and their Impact in Accessing Depression Treatments 
 
In addition to language preferences, well-established stigma fears associated with 
a depression diagnosis and its treatment are believed to play a fundamental role in the 
underutilization of mental health resources. Common fears include being negatively 
perceived by mental health professionals or believing that personal problems should not 
be disclosed to others outside the home (Alvidrez & Azocar, 1999; Edge & Rogers, 
2005; Eisenman et al., 2008; Van Hook, 1999). In Latinas, stigma towards mental illness 
has also been identified as stemming from the fear of being perceived as “loca” or crazy 
(Collins et al., 2008; Pincay & Guarnaccia, 2007). Immigrant Latinas’ reports of stigma 
towards mental health services are higher relative to non-Hispanic White American 
women (Nadeem et al., 2007). This is concerning given that in immigrant Latinas, 
stigma is predictive of decreased interest in receiving psychological services (Rastogi, 
Massey-Hastings & Wieling, 2012) and of treatment noncompliance, even after 
controlling for socioeconomic variables (Nadeem et al., 2007).  Increased stigma has 
also been associated with less likelihood of disclosing depression to either family or 
friends (Vega, Rodriguez & Ang, 2010). Therefore, treatments that conceive depression 
as originating from external factors (i.e., individual’s environmental context) in contrast 
to internal factors such as cognitions, or genetics have been proposed as more 
appropriate for this population (Kanter, Santiago-Rivera, Rusch, Busch, & West, 2010; 
Santiago-Rivera, Kanter, Benson, DeRose, Illes & Reyes, 2008).  




With the goal of reducing depression treatment disparities among Latinos, it is 
critical to first examine their general attitudes toward different types of mental health 
treatment. In general, Latinos’ attitudes towards the use of medication for the treatment 
of depression have been predominantly negative. Findings by Cabassa and colleagues 
(2007) indicated that almost 50% of patients in their sample believed that using 
antidepressants would result in addiction and reported apprehension and ambivalence 
toward their use. Similarly, Cooper et al. (2003) showed that Latinos preferred 
antidepressant medication significantly less than non-Hispanic Whites. A 
comprehensive literature review regarding the use of antidepressants noted that 
depressed Latinos were more likely to be noncompliant than depressed non-Latino 
White Americans (Lanouette, Folsom, Sciolla & Jeste, 2009). Further, a study 
comparing adherence to medication treatment among a sample of Latino patients 
showed that those who described their English proficiency to be less than “good” or 
“excellent” were more likely to discontinue the use of antidepressants in comparison to 
their more proficient counterparts, even after controlling for relevant demographic and 
clinical variables (Hodgkin, Volpe-Vartanian & Alegría, 2007), which underscores the 
need for additional treatment options for this group.    
Organista (2000) suggested that a possible reason for the overall resistance 
toward taking medication was that using pharmacotherapy would go against the much-
valued belief of being able to “poner de su parte” (put effort or do their part) in this 
group (Interian et al., 2010; Pincay & Guarnaccia, 2007). Medication therefore, is 
thought of as interfering with the process of individual contribution to one’s recovery. 
Given the current state of evidence and in order to promote treatment adherence and 
7 
 
prevent both treatment dropout and stigma related concerns, it may be more beneficial to 
focus on the use of effective psychosocial treatments with Latinos.  
In fact, Latinos tend to endorse positive attitudes towards the psychosocial 
treatment for depression. Karasz and Watkins (2006) found that Latinos receiving 
treatment in primary health facilities expressed hope regarding the effectiveness of 
depression treatments available to them, including physician consultation, medication, 
but most of all, psychotherapy. Patients believed that physicians could most assist them 
through supportive talk, including advice, guidance, and comfort. Moreover, a sample of 
low-income, depressed Latinos perceived their depression as having a social or 
environmental origin (e.g., as caused as an emotional reaction to life stressors) or as a 
psychological problem (e.g., low self-image, low self-esteem). According to these 
beliefs, the study sample reported that depressed individuals would be more likely to 
benefit from psychotherapy and not antidepressant medication (Karasz, Sacajiu & 
Garcia, 2003).  
 In general, speaking intimately in a supportive setting was most commonly 
considered by Latino patients to be helpful for depression (Karasz, Sacajiu & Garcia, 
2003). Research by Cooper et al. (2003) showed consistent results and further suggested 
that Latinos were more likely than non-Hispanic White individuals to regard counseling 
as acceptable. In another study, after being presented with a vignette of an individual 
experiencing depression, 75% of a Latino sample agreed that counseling would help 
restore this individual's functioning to a normal level  (Cabassa, Lester & Zayas, 2007). 
Additionally, it has been reported that in comparison with non-Hispanic White 
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American women, immigrant Latinas are more likely to want treatment (Nadeem et al., 
2007).  
1.7 Attrition from Depression Treatments as another Source of Treatment Disparities 
among Latinos 
 
The experience of barriers associated with the underutilization of mental health 
services mentioned previously may also lead to other complications that can hinder the 
process of informing effective depression treatment practices for Latinos. Although 
Latino patients have endorsed more positive attitudes toward psychotherapy overall, 
high treatment attrition rates remain problematic. Though scant, when treatment research 
has been conducted with Latino participants, attrition rates reported have been higher 
than those established for White non-Hispanic participants (Organista, Muñoz & 
Gonzales, 1994). In their CBT depression study, Organista and colleagues (1994) 
reported dropout rates of 58%. The authors speculated that such high attrition rates could 
be in part due to half of the sample having serious medical conditions. In other studies 
however, similar dropout rates have been evidenced. Miranda et al. (2003) reported only 
32% of low-income minority women (approximately half of whom were Hispanic) 
attended 6 or more sessions of an 8-session CBT intervention. This pattern has also been 
observed in individual counseling settings, in which it has been estimated that 50% of 
Latino clients who seek these services do not return after the first session (La Roche, 
2002; Sue, Zane & Young, 1994.; Walitzer, Dermen, & Connors, 1999). In general, 
attrition rates of Latinos from research studies are disproportionally large in comparison 
to reports ranging from 0% to 43% in the overall population across different 
psychosocial therapies (Cuijpers, van Straten, Andersson, & van Oppen, 2008). 
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Several studies have proposed different strategies to address the high dropout 
rates evidenced in these populations. In earlier research, Sue, Fujino, Hu, Takeuchi & 
Zane (1991), found that for clients whose primary language was not English, ethnic and 
language match was a predictor of length and outcome of treatment. In a more recent 
study, a trial comparing Motivational Enhancement Therapy (MET) and Counseling as 
Usual for Spanish-speaking substance users, 66% of participants (n = 405) completed 
the 3-session protocol. Reasons proposed by the investigators for the unusually high 
retention rates for this population included the delivery of services in Spanish, and the 
client-centered, collaborative-style of MET (a derivative of Motivational Interviewing) 
(Carroll et al., 2009). However, the low attrition rates could also have been attributed to 
the few treatment sessions required in this study. Further, in a pilot study (N = 15) that 
delivered a 12-session Spanish version of CBT for major depression to primary care 
Hispanic patients, only 4 participants dropped out, which the authors believed to be 
favorable in comparison to higher attrition rates reported in the literature. The 
researchers recommended understanding clients’ unique cultural characteristics and 
hypothesized that retention and treatment success was a result of utilizing fluent, 
culturally-relevant Spanish and their various efforts in promoting treatment attendance, 
such as contacting clients at their scheduled appointment time if they had not arrived 
(Interian, Allen, Gara & Escobar, 2008). In general, addressing low retention in this 
group has shown to be crucial as revealed by reports that participants who remained in 
treatment significantly reduced their depressive symptoms (Miranda et al., 2003).   
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1.8 Depression Treatment Research Outcomes for Spanish-Speaking Latinos 
Depression treatment studies that have included Spanish-speaking Hispanic 
samples are noticeably scarce, but a small literature suggests that CBT specifically is an 
efficacious treatment intervention for this group. In 1995, Muñoz and colleagues were 
the first to develop and evaluate a CBT depression manual for use in Spanish-speaking 
Latinos, further editing it in 2000 to incorporate sessions that placed an emphasis on 
interpersonal relationships (Muñoz et al., 1995). In their first trial, 45 impoverished 
Puerto Rican participants with low levels of education were randomized to either CBT 
delivered in group format, to treatment as usual, or to a medication group. Findings 
indicated that group CBT showed superior results in relation to the other treatments 
(Reyes, Vera, Bernal & Huertas, 2002 as cited in Bernal & Reyes, 2008). 
Miranda and colleagues (2003) have also found evidence that CBT was effective 
in reducing depressive symptoms in a sample that consisted of mostly low-income, 
young, Latinas. In their study, they compared the effectiveness of traditional cognitive-
behavioral group therapy and the same therapy with a supplemental case management 
for impoverished Latina medical outpatients. The Spanish- and English-speaking 
patients in this sample responded equally well to cognitive-behavioral therapy alone 
(Miranda et al., 2003). In another study, Lara, Navarro, Rubí, & Mondragón (2003) 
recruited participants in Mexico to evaluate the effectiveness of a 6-week 
psychoeducational group approach and a one-time individual orientation that also 
included psychoeducational material. The researchers saw an overall reduction in 
depressive, anxiety, and somatic symptoms in both conditions. Further, in a sample of 5 
Latinas, Gelman et al. (2005) saw a significant reduction in depression scores after a 12-
session CBT intervention. Finally, in a sample of low-income African American (n = 
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117), White American (n = 16), and Spanish and English-speaking Latina women (n = 
134) with mild to moderate depressive symptoms, Miranda et al. (2003) found that 
treatment gains of 6-month pharmacotherapy and 8-week CBT (but not for the control 
group that consisted of providing community referrals) were sustained as indicated by a 
1-year follow-up. More than 50% of participants who completed at least 6 weeks of 
CBT did not endorse criteria for depression at the year follow-up. Despite the 
encouraging results, authors have discussed disparities in mean reductions of depressive 
symptomatology in Latinos relative to those evidenced in non-Latino White samples, 
which have been hypothesized to occur as a result of early termination of therapy 
(Interian, Allen., Gara & Escobar, 2008). In fact, research has suggested that Latinos 
who remain in treatment evidence significant reductions in depressive symptoms 
(Miranda et al., 2003).  
Recommendations to Increase the Likelihood of Retention and Positive Outcomes 
The lower reductions in depressive symptomatology and its close association 
with high attrition rates reported in this group relative to the overall population indicate 
the need to consider Latinos’ preference toward mental health services prior to the 
implementation of psychosocial treatments for depression. Miranda (1976) and Gelman 
(2004) advocated for short-duration treatments that provide direct problem-focused 
guidance given the various life circumstances that require immediate attention in this 
group. A second consideration is to utilize treatments that are in accordance with the 
view of “poner de su parte” which was introduced in a previous section. Among this 
population it is considered favorable to put effort into one’s recovery by being an active 
participant of the therapeutic process (Organista, 2000). A third consideration is the role 
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of stigma toward mental health treatment, which has been frequently recognized as an 
important deterrent toward seeking services among Latinos (e.g., Vega, Rodriguez & 
Ang, 2010) and cause of attrition (Sirey et al., 2001). Evidently, treatments that reduce 
stigma should be selected. For example, interventions that explain depression as a result 
of individuals’ internal processes contribute to this stigma and to the fear of being 
perceived as “crazy” (Collins et al., 2008; Pincay & Guarnaccia, 2007) among Latinos. 
A final consideration in selecting treatments to address the mental health needs of this 
group is that Latinos comprise various subgroups-each reflecting a complex combination 
of individual cultural patterns and values. As a result, a treatment approach that allows 
for individual tailoring, that is, one which utilizes idiographic treatments aimed towards 
accommodating personal values on a case-by-case basis without global, culturally-
specific modifications, may be best suited to address the depression care needs of this 
population.  The use of such treatments could potentially address key issues pertaining 
to generalizability when individuals do not share characteristics identical to the clients 
for whom the intervention was validated. As a result of Latinos’ high within-group 
heterogeneity, this is a particularly important strength of interventions allowing 
individual tailoring.  
1.9 The Promise of Behavioral Interventions in Treating Depression among Latinos 
Despite evidence pointing to CBT as an efficacious psychosocial treatment for 
depressed Spanish-speaking samples, treatments coming more specifically from a 
behavioral tradition may be of particular utility in this group in terms of practicality, 
emphasis in taking responsibility and accountability for living according to one’s values, 
and making life changes as opposed to addressing illness. In fact, behavioral treatments 
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may be especially well-received by Latinos as such approaches often exemplify the 
valued-belief of being able to do their part in one’s recovery (“poner de su parte”; 
Organista, 2000).  
Support for a focused behavioral treatment was first provided by Comas-Diaz 
(1981) who evaluated the efficacy of group-format behavioral therapy, group-format 
cognitive therapy, and a waitlist control was assessed in a small sample of Latinas (N = 
26). Study results showed a 64% and 51% mean reduction of depressive symptoms for 
those assigned to cognitive therapy and behavioral therapy, respectively. Both of these 
treatments demonstrated superior results relative to the waitlist control group, and 
comparable results to each other in reducing depressive symptomatology. Nonetheless, 
treatment gains did not persist at a 5-week post-treatment follow-up assessment for those 
randomized to cognitive therapy, but maintained for participants in the behavioral 
therapy condition. The author posited that participants sustained improvement in the 
behavioral treatment condition as a result of scheduling rewarding activities. Moreover, 
Comas-Diaz (1981) indicated that through scheduling rewarding activities, participants 
were able to perceive control over everyday situations in contrast to the lack of control 
that minorities often experience when confronting marginalizing experiences, including 
poverty and racism. In fact, behavioral treatments may be especially well-received by 
Latinos as such approaches often exemplify the valued belief of being able to do their 
part in one’s recovery (“poner de su parte”). In particular, a behavioral treatment that has 
received wide empirical support in the general population, and more recently, 
demonstrated promise in depressed Spanish-speaking Latinos is Behavioral Activation.  
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1.10 What is Behavioral Activation? 
 
 The theoretical framework of Behavioral Activation (BA) is based on the 
principles of learning theories, for which positive and negative reinforcement play a 
significant role. BA conceptualizes depression as originating from a lack of positive 
reinforcement for healthy, nondepressive behaviors (Ferster, 1973; Lewinsohn, 1974; 
Skinner, 1953), while being maintained by sources of positive reinforcement towards 
unhealthy, depressive behavior (e.g., receiving sympathy from others) as well as through 
negative reinforcement, such as avoiding unpleasant situations or responsibilities 
(Lewinsohn, 1974).  
According to the BA model, by decreasing engagement in pleasant activities, 
depressed individuals create an environment deplete of positive reinforcement 
possibilities (MacPhillamy & Lewinsohn, 1974). Lewinsohn and Graf’s research (1973) 
suggested a negative association between depressed mood and frequency of pleasant 
activities. More recently, research has also suggested that decreased environmental 
reward is significantly associated with depression (Carvalho, Trent, Hopko 2011). 
Therefore, through BA, clients learn to schedule positive healthy activities and monitor 
their respective mood. It is expected that there will be a proportional increase between 
the frequency of pleasant activities in which the individual engages and positive 
interactions with their environment, resulting in elevated mood and subsequently, in 
improvements in cognitions (Hopko, Lejuez, Ruggiero & Eifert, 2003). 
In a randomized controlled trial conducted by Jacobson and colleagues (1996) 
three components of CBT were evaluated to determine the contribution of each in 
treating depression. The components were: 1) the behavioral activation part of CBT 
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(BA), 2) BA in addition to skills training, which are thought of as assisting in modifying 
dysfunctional automatic thoughts (AT), and 3) the full cognitive behavioral treatment, 
which included the two previous components in addition to addressing core beliefs and 
the schema associated with depression. The authors concluded that contrary to previous 
hypothesized outcomes, no one treatment was more effective than the others. In 
addition, when examining the purported mechanism of change for the full cognitive 
behavioral treatment (i.e., change in negative attributions), the authors reported that all 
groups showed equal improvement in negative attributions as those who received the 
intervention component specifically aimed at modifying cognitive structures. In 
addition, for those assigned to receive BA, fewer negative cognitive attributions early 
during treatment predicted more improvements in depression relative to those with more 
negative cognitive attributions. A 6-month and 2-year follow-up of this seminal study 
indicated sustained progress of the interventions (Jacobson et al., 1996; Gortner et al., 
1998). This seminal study provided evidence for a parsimonious version of CBT and 
against the necessity to directly address dysfunctional thinking with additional cognitive 
components.  
In a subsequent randomized trial consisting of 241 depressed adults, participants 
were randomly assigned to one of four treatment conditions: BA, CBT, antidepressant 
medication or a medication placebo (Dimidjian et al., 2006). BA and the antidepressant 
medication were most effective for moderately to severely depressed patients but as 
effective as the other interventions for mildly depressed patients. However, those 
randomized to BA sustained progress and remained in treatment longer than those 
randomized to antidepressant medication. 
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  Currently, two major BA approaches are widely used. One of these approaches 
was proposed by Jacobson, Martell and Dimidjian (2001). The other major approach 
was developed by Lejuez and colleagues (2001; 2011) and is referred to as the Brief 
Behavioral Activation Treatment for Depression or BATD, for short. In contrast to the 
intervention developed by Jacobson and colleagues (2001), BATD offers a more 
behavior-based treatment; the treatment model does not employ practices that are 
associated with other psychosocial treatment approaches, including cognitive rehearsal 
(e.g., Jacobson et al., 1996), skill building, such as assertiveness and communication 
skills (e.g., Jacobson et al., 1996), mindfulness (e.g., Dimidjian et al., 2006; Coffman, 
Martell, Dimidjian, Gallop & Hollon, 2007), or exposure to situations that the client 
would usually avoid. In addition, BATD consists of 10 sessions, more than half the 
number traditionally required by the BA approach utilized by Jacobson et al. (2001). 
BATD has been described as being more efficient, less costly and more straightforward 
than the other BA approach (Barraca Mairal, 2009; Hopko, Lejuez, LePage, Hopko & 
McNeil, 2003). Therefore, the specific BA approach has been described as highly 
practical (Barraca- Mairal, 2009) and suggests the particular utility of BATD in Latinos 
with Spanish-language preference. In addition, BATD has been identified as a treatment 
suitable for the incorporation of clients’ ideographic needs which is optimal given the 
high within-group heterogeneity of US Latinos, which was outlined in a previous section 
(for a more extensive review of the differences between the two BA techniques, please 
see Barraca Mairal, 2009 and Hopko et al., 2003).  
Further supporting the use of BATD its efficacy has been established with a 
variety of samples, including patients in a community mental health center (Lejuez, 
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Hopko, LePage, Hopko, & McNeil, 2001), patients in an inpatient psychiatric facility 
(Hopko, Lejuez, LePage, Hopko, & McNeil, 2003), as a supplemental intervention for 
patients with coexistent Axis II disorders, (Hopko, Sanchez, Hopko, Dvir, & Lejuez, 
2003), and cancer patients (Hopko, Bell, Armento, Hunt & Lejuez, 2005).  
To date, 4 meta-analyses have revealed the effectiveness of BA approaches 
broadly including BATD specifically in treating depression. Cuijpers, van Straten, 
Warmerdam  (2007) found that pleasant activity scheduling was superior to other 
psychological treatments and equal to the full CBT at end of treatment and follow-ups, 
reporting an effect size of 0.87. A later meta-analyses conducted by Ekers, Richards, and 
Gilbody (2008) included 17 studies and concluded that BA was superior to controls, 
brief psychotherapy, supportive therapy, and equal to CBT. These results were 
confirmed by a more recent meta-analysis that compiled 34 studies and explored 
whether more complex versions of BA accounted for more variance in comparison to 
more parsimonious versions of the approach (Mazzucchelli, Kane & Rees, 2009).  In 
this recent meta-analysis, BA also showed superiority to control conditions in addition 
to suggesting that the variants of BA did not differ significantly from each other (p = 
.23).  
1.11 Use of Behavioral Activation in Spanish-Speaking Latinos 
 
Following the work of Comas-Diaz (1981) two decades earlier, Kanter et al. 
(2010) developed a culturally-modified version of BA in Spanish from the original 
approach proposed by Jacobson et al. (2001). The researchers conducted an initial 
evaluation of the culturally adapted version of BA in an open-label trial pilot study with 
10 Latinas. In this version of BA, in addition to scheduling pleasant activities, clinicians 
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utilize cognitive rehearsal, skill building, mindfulness, exposure to activities for which 
avoidance is displayed, and role-playing. As part of their modified treatment, Kanter’s 
team indicated simplifying the treatment rationale and paying close attention to values 
commonly attributed to Latinos that would affect the course of treatment. Among these 
values was the centrality of family in individuals’ lives (“familismo”), the establishment 
of differential matriarch and patriarch roles (“machismo” and “marianismo”), and 
sympathy in daily interactions (“simpatía”). During the treatment for example, therapists 
requested that clients integrate their family members into the treatment by having them 
attend the sessions with them (Kanter et al., 2010). The evaluation indicated a significant 
decrease in depression severity on the Beck Depression Inventory-II at post-treatment 
which represented a large effect size (d = 1.67). Additionally, there was a significant 
reduction in depressive symptoms for the intent-to-treat sample that also indicated a 
large effect (d = 1.07). Although the authors posited that BA’s effectiveness was 
possibly a result of the cultural modifications, a lack of a comparison group prevented 
empirical support to this statement. Despite the promising results, retention in this study 
was low: only 3 clients completed the 12-session treatment. The authors noted that the 
rate of session attendance was high in comparison to other psychosocial depression 
interventions delivered at the same mental health facility. The authors attributed the 
relative success of retention rates to the treatment’s simplicity and straightforward 
rationale, which compared to CBT have been regarded as easier to explain and to 
implement into clients’ daily lives (Hollon, 2000). Among other study limitations of this 
trial were the inclusion of only female participants, no examination of the BA proposed 
mechanisms of change, a lack of follow-up data, and no systematic evaluation for 
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guiding the cultural modifications they performed to the original BA manual (Kanter et 
al., 2010). Recent work by Kanter and colleagues (in press) supports the efficacy of this 
culturally-modified BA. The authors conduced a RCT between BA (n = 21) and an 
unstructured treatment as usual (TAU) condition (n = 22) among monolingual Latinos. 
The authors reported that people in the BA condition completed more sessions than 
those in the TAU condition. Further, there was a significant session by treatment by time 
interaction (p = 0.05) such that participants who completed more sessions of BA showed 
greater improvements in depression. Limitations of the study include the lack of 
examination of proposed BA mechanisms, the unstructured and unspecified nature of the 
TAU condition, and the examination of mean score values as opposed to individual 
change over time.  
1.12 Rationale for Using (BATD) as a Treatment among Spanish-Speaking Latinos  
 
Although Kanter and colleagues (2010; in press) provided promising evidence 
for BA, there are several reasons to consider BATD in the treatment of depression 
among Latinos with Spanish language preference. The first reason is that BATD’s 
idiographic nature may allow the incorporation of individuals’ unique personal values. 
The process of value identification and subsequent activity selection is entirely client-
directed and focused; with the help of the therapist, the client identifies important life 
areas (e.g., relationships), values within those life areas (e.g., be an involved parent), and 
activities in which the client can engage that are congruent with those values (e.g., 
attend the child’s extracurricular activities). Therefore, the therapist does not make any 
assumptions as to the individual’s values. This may be an especially important feature of 
BATD to implement within Latinos in the US, given the high degree of within-group 
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heterogeneity characterizing this group. Latinos represent over 20 countries, each 
embedded within different sociocultural contexts and histories. As such, BATD strikes 
an appropriate balance in maintaining cultural sensitivity by tailoring treatment to 
diverse cultural groups while providing for attention to individual differences.  
An additional reason for considering BATD as a potentially beneficial 
depression treatment within this group is that it has shown great potential in reducing the 
likelihood of drop-outs in underserved minority samples facing similar problematic 
retention rates, treatment seeking challenges, and treatment utilization disparities as US 
Latinos (e.g., Fortuna, Alegria & Gao, 2010; Alegria et al., 2002; Kanter et al., in press), 
while also decreasing depressive symptomatology (Daughters et al., 2008; Magidson et 
al., 2011). BATD is also able to accommodate the needs of low-literacy clients through 
modified treatment materials (Lejuez et al., 2011) that address the needs of a variety of 
clients belonging to diverse educational backgrounds.  
Collectively these characteristics suggest BATD may be a culturally-relevant 
treatment in that it is 1) accessible, 2) congruent with the client’s cultural values, thereby 
acknowledging individual differences among subgroups, and 3) inclusive of the client as 
an active participant of his or her intervention development (see criteria by Muñoz & 
Mendelson, 2005 as cited by Comas-Diaz, 2006; Rogler, Malgady, Costantino & 
Blumenthal, 1987).  Based on these reasons Collado and colleagues (2013) evaluated the 
BATD in an open-label trial with 10 Latinos who lacked English language proficiency 
and self-reported a Spanish-language preference.  





The open-label trial conducted by Collado and colleagues provided initial 
evidence suggesting the promise of BATD in treating depression in this group. 
Hierarchical Linear Model analyses revealed that over the course of the treatment, 
depressive symptomatology decreased (β = -1.64, SE = 0.21, p < .001) and the proposed 
BATD mechanisms, activity engagement (β = 1.91, SE = .0.79, p = .04) and 
environmental reinforcement (β = 0.45, SE = .16, p = .02) increased. Effect sizes for 
these clinically-relevant variables pre- and post-treatment ranged from medium to large 
(d’s = 0.50- 1.45).  Further, increases in activation corresponded concurrently with 
decreases in depression (β = -0.14, SE = 0.04, p = .01), such that while activation 
increased, depression decreased simultaneously. On the other hand, environmental 
reinforcement predicted decreases in depressive symptomatology (β= -0.26, SE= 0.11, p 
=.04), such that when environmental reinforcement increased, depressive 
symptomatology decreased in the subsequent session. In addition, paired t-tests revealed 
sustained clinical gains in depression and activation (p > .05), and an increase in 
environmental reinforcement at the one-month follow-up (t = -2.63, df = 7, p = .03). Of 
note was that treatment adherence and attendance were high in this small sample; eight 
participants completed all treatment sessions, and the remaining two participants 
completed 4 sessions. Those who completed treatment did so between 10 weeks and 13 
weeks. Mean percentage rate of homework completion was 86.54 %, exceeding rates 
observed in the literature (e.g., Floyd et al., 2004). Further, in-depth interview results 
also conducted at the one-month follow-up suggested high levels of treatment 
acceptability and did not suggest the need for specific changes to BATD’s content, 
cultural or otherwise. 
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1.14 Extensions to the Preliminary Study of BATD with Spanish-speaking Latinos 
 
Although the preliminary findings of BATD delivered to a small sample of 
Latinos with Spanish-speaking preference were positive, the study had several 
limitations, primarily consisting of a small sample size, lack of a contact-time matched 
control, and the utilization of elevated depressive symptoms rather than MDD as 
inclusion criteria. In fact, in their publication, Collado and colleagues specifically called 
for the inclusion of all of these components in future work.  First, a control group would 
enable further investigation as to whether the observed beneficial effects of BATD on 
depressive symptomatology and proposed treatment mechanisms could not be better 
explained by increased individualized attention that clients received or other non-
specific therapy-related factors. With a larger sample size as a study extension, sufficient 
power to detect significant changes as a result of participants undergoing treatment 
would be made possible. Finally, the inclusion of an MDD diagnosis for study eligibility 
would allow for determining the efficacy of the intervention in treatment of clinical 
depression. This is an important extension given that BA has been found to be most 
effective for moderately to severely depressed patients but as effective as the other 
interventions for mildly depressed patients (Dimidjian et al. 2006). Therefore, an 
extension of Collado and colleagues’ preliminary study would continue to establish the 
efficacy of the BATD intervention programmatically (e.g., Carroll & Nuro, 2002) in 
treating depression in Latinos whose preferred language is Spanish.  
Thus, the current study involved a randomized controlled trial (RCT) with 46 
depressed Latinos in the community who report a preference of Spanish language 
randomized to BATD (n = 23) or to Supportive Counseling (SC) (n = 23). To our 
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knowledge, this constitutes the first effort toward conducting a RCT comparing a 
behavioral intervention to SC with a sample consisting solely of Latinos in the US who 
report Spanish language preference. This is a sample that has been historically 
underrepresented in both clinical and research samples (Miranda et al., 1996; Wells et 
al., 2001).  
The study consisted of three main aims. The first aim was to compare the BATD 
Spanish translation and a SC condition on participants’ levels of depression. The second 
aim compared group differences on the proposed mediators of BATD, including 
activation and contact with environmental reinforcement. The third aim examined SC 
and BATD group differences on key conceptually-relevant variables associated with 
treatment completion and outcomes in Latinos, such as treatment satisfaction (e.g., 
McCabe et al., 2009), therapeutic alliance (e.g., Añez, 2005), and perceived stigma (e.g., 
Sirey et al., 2001). These variables have shown to affect treatment outcomes and 
retention in this population. In addition, dropout rates were compared between 
conditions in the context of the third aim.  
For the first aim, we expected that participants randomized to BATD would 
evidence greater reductions in depressive symptoms and a higher percentage remission 
of MDD relative to participants randomized to the SC condition throughout treatment 
course at a one-month follow-up. In the second aim, we hypothesized that participants 
assigned to the BATD condition would evidence greater increases in activation and 
contact with environmental reinforcement relative to those assigned to the SC condition 
over the course of treatment and at the one-month follow-up. We also expected increases 
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in activation and contact with environmental reinforcement to correspond with decreases 
in depression.  
Finally, as part of Aim 3, we expected that relative to participants assigned to the 
SC condition, participants randomized to BATD would evidence higher treatment 
satisfaction over treatment course. This outcome is hypothesized given the heavy 
emphasis of BATD on putting effort into one’s recovery from depression (”poner de su 
parte”), a treatment expectation highly valued in this population (e.g., Cabassa et al. 
2007; Organista 2000). Further, we hypothesized greater therapeutic alliance in the 
BATD condition given the collaborative approach expected to emerge between the client 
and the therapist in this treatment condition (Lejuez, Hopko, Levine, Golkhar & Collins, 
2006).We also hypothesized that as a result of BATD’s conceptualization of depression 
as originating from the lack of environmental reinforcement, perceived stigma levels 
would decrease relative to the SC condition over the course of treatment. Finally, we 
expected that treatment retention would be greater in the BATD condition than in the SC 
condition based on previous findings suggesting this trend (e.g., Daughters et al., 2008; 





Chapter 2: Method 
2.1. Overall Design 
 
Forty-six depressed Latinos from the community who reported a preference 
toward Spanish language were randomized to receive individual BATD (n = 23) or an 
individual contact time-matched SC condition (n = 23). This design allowed the 
examination of treatment group differences in depression, activity level and contact with 
environmental reward, treatment adherence, treatment satisfaction, perceived stigma 
toward receiving depression treatment, and therapeutic alliance between conditions 
which comprised our first, second and third aim.  
2.2. Recruitment  
 
Participants (N = 46) were primarily recruited from the District of Columbia 
Metro area, including Montgomery and Prince George’s counties in Maryland. The 
current Latino population in the DC Metro Area was estimated to be 700,000, in 2010, 
an increase of 62% from the previous decade (Fraga et al., 2010; U.S. Census Bureau, 
1990; U.S. Census Bureau, 2000). Recruitment followed a similar pattern as the open 
label trial that served as basis for the proposed study. Specifically, participants were 
recruited through various community organizations that served predominantly low-
income Spanish-speaking Latinos, flyers, and radio stations for the Spanish-speaking 
community of the DC Metro area. Flyers were posted in grocery stores, bus stops, public 
libraries, and community centers. Authorization was sought prior to the distribution of 
recruitment materials to be in accordance with all local and national laws, as well as 





Initial eligibility was determined via a telephone screener, which included 
questions from the Mood Disorders, Substance Use and Dependence, and Psychotic 
Disorders modules of the Structured Clinical Interview for DSM-IV-TR (SCID-IV; 
First, Spitzer, Gibbon & Williams, 2002). Inclusion criteria consisted of the following: 
1) be a minimum of 18 years of age, 2) be of Latino descent, 3) self-report Spanish-
language preference, 4) meet current MDD criteria, 5) have completed the 4th grade or 
higher either in their country of origin or in the US, 6) not have current substance abuse 
or dependence, 7) have no Bipolar or Psychotic Disorders, and 9) not be currently 
receiving psychotherapy, and 10) if currently taking antidepressants, demonstrate 
pharmacological stability as indicated by 3 or more consecutive months of use. 
Excluded individuals were referred to mental health resources within the community.  
After a participant was deemed eligible over the telephone, he or she was 
provided with a brief description of the study and participation. Participants were then 
scheduled for an appointment at the University of Maryland’s Center for Addiction, 
Personality, and Emotion Research (CAPER) to complete the baseline assessment and to 
attend the first BATD session. Participants were informed over the telephone that final 
eligibility would be determined at the baseline session.  
When participants attended the first session to complete the assessments, a 
research assistant (RA) fluent in Spanish greeted them at CAPER. At the beginning of 
the appointment, the RA reviewed study procedures, answered any questions regarding 
the study, and obtained verbal informed consent. Ms. Collado was available to answer 
questions about the treatment, if needed. Along with the verbal informed consent which 
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was approved by the IRB, participants were informed about the certificate of 
confidentiality obtained with the purpose of protecting any identifiable information they 
provide during the treatment from forced disclosure. Of particular concern was 
protecting participants’ immigration status, whose disclosure could potentially result in 
adverse legal consequences. After providing verbal informed consent, a member of the 
staff trained in administering the SCID-IV, administered the Mood Disorders, Substance 
Use and Dependence, Psychotic Disorders, and Anxiety Disorder modules of the 
Interview to confirm eligibility for the study and characterize the sample’s 
psychopathology appropriately. SCID-IV interviews were audiotaped and uploaded to a 
password protected database so that the diagnostic reliability of 20% of all SCID-IV 
interviews could be assessed. The recording was erased within a week, after the 
reliability check was conducted.  
Participants did not receive monetary compensation for attending therapy. 
However, they earned $15 for completing questionnaires at the baseline assessment 
(conducted immediately prior to session 1), at the end-of-treatment assessment 
(conducted immediately prior to session 10), and at the follow-up assessment (conducted 
one month after session 10). Participants earned $10 for the remaining scheduled 
assessment points, with an additional $5 for transportation at each time point. 
Participants were only paid for the assessment points that they completed.  
In the case that participants were not eligible for the study during the baseline 
assessment, they were paid for this meeting. These participants were provided with 
mental health referrals in the community. Those who did qualify for the study were 
asked to complete Spanish-language questionnaires in a private room, with the option of 
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completing the questionnaires by themselves or being read the questions by the research 
staff. The completion of the assessments during the first and last meetings took up to 70 
minutes, and up to 30 minutes for the remaining meetings. After their completion, 
participants were compensated.  
A staff member not involved in the study conducted the randomization using a 
computerized random number generator and informed the participant’s therapist of the 
assigned therapy condition in person. We used a randomized block design for gender. 
Each research assistant that conducted assessments was blind to participants’ assigned 
treatment condition. Blinding was facilitated by the fact that participants completed 
identical assessment measures regardless of their assigned condition throughout the 
course of the study. This removed any need for research assistants to be informed about 
participants’ randomization outcome. Therapy commenced thereafter, and therapy 
sessions lasted approximately 60 minutes.  
2.4. Overview of the BATD  
 
The current trial utilized the most current version of the Spanish BATD manual 
(Lejuez et al., 2011; Maero et al., unpublished). As outlined in the manual, the first 
session of BATD focused on providing depression psychoeducation, reviewing the 
treatment’s rationale, discussing the importance of monitoring daily activities, 
describing session attendance policies and stressing the importance of attending every 
session weekly, and explaining the relationship between treatment adherence and the 
likelihood of treatment success. Starting in the first session and continuing until the end 
of treatment, the homework assignment focused on participants monitoring their daily 
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activities until the subsequent session and reporting a numerical rating of both 
enjoyment and importance for each activity completed.   
  The second BATD session consisted of briefly reviewing the content of the 
previous session, discussing activities completed as well as the ratings of enjoyment and 
importance, making use of the completed daily monitoring record forms, and assessing 
any difficulties associated with homework completion. The remainder of the second 
session was devoted to a thorough discussion of life areas (e.g., relationships) and 
corresponding values (e.g., be a caring husband) important for participants, with the 
purpose of selecting activities consistent with these values in future sessions (e.g., taking 
spouse on monthly dates) 
  During the third session, participants worked on selecting at least fifteen 
activities they considered rewarding (taking into consideration both expected enjoyment 
and importance) that are consistent with life areas they deemed important and their 
expressed personal values. These could constitute activities already a part of the 
participants’ schedule or new activities.  Participants proceeded to rank the activities in 
terms of difficulty such that they completed easier activities toward the beginning of 
treatment and progressed towards more challenging activities. From the fourth through 
the tenth sessions, participants worked toward accomplishing three to five activities on 
their list that reflected their values.  
  Specific to session 5, participants were introduced to “contracts”, which provided 
the opportunity to request assistance from friends and family in order to accomplish 
selected activities because the activity is challenging for participants or because 
company may potentially increase the “enjoyment” and “importance” of the activity.  Of 
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note is that discussing contracts with individuals from a supportive network did not 
require that participants disclose they are seeking depression treatment or sign any 
document; rather, participants could simply ask these individuals to join them in 
completing the specific activity.  
  No new material was introduced beyond this point. Sessions 6 through 10 
consisted of continued engagement on meaningful activities and daily monitoring, as 
well as of discussions of an individualized post-treatment plan within a behavioral 
activation framework of scheduling activities corresponding to participants’ values and 
drafting “contracts” with people in their support network. Throughout treatment, 
depressogenic and non-depressogenic patterns were identified with the assistance of the 
monitoring forms and ratings of enjoyment and importance.  
2.5 Overview of SC  
 
To control for the non-specific elements of therapist contact, half of the clients 
received SC. The SC manual was modeled after Novalis, Rojcewicz and Peele (1993). 
SC did not follow a clearly defined theoretical model and was best described as offering 
the client support. The discussion for each session was patient-driven, and the manual 
included training in therapy using SC techniques including reflections, empathic 
listening, encouragement, help in feelings and experiences exploration and expression, 
without advice-giving, solution-offering or skills-acquisition. The manual was organized 
in a way that reviewed the basis for supportive psychotherapy, the meaning of 
establishing a supportive relationship, steps for beginning the therapy session, session 
management, crisis management, and ethical factors in supportive psychotherapy.  
Therapists were trained in these procedures, in using non-directive techniques and in 
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avoiding BATD techniques. These topics were covered in different chapters within the 
manual. Features such as the use of a therapist manual (with discussion topics) and 
journal writing homework forms were incorporated into SC. Further, each session ended 
with one of three relaxation exercises: progressive muscle relaxation, visual imagery, 
and breathing retraining. Amount of homework assigned was matched with BATD. 
Clients were asked to write one entry each day about any feelings that they were 
experiencing.  
2.6. Therapists and Research Staff 
 
A CAPER research assistant, two volunteer research assistants, and Ms. Collado, 
all of whom have native Spanish fluency and training in administering the SCID-IV, 
administered the semi-structured interview and conducted weekly assessments. In every 
case, SCID-IV interviewers were different from the therapist assigned to the client. All 
RAs were supervised by Ms. Collado. Therapists for the proposed project consisted of 
five post-baccalaureate research assistants, a master’s level graduate student, and two 
graduate students from CAPER, including Ms. Collado. All therapists had fluency in 
Spanish. Given the differing degrees of clinical training among the therapists, 
randomization across conditions took place to control for therapist effects. Under the 
supervision of Drs. Lejuez and MacPherson (Dissertation Proposal Co-Chairs), Ms. 
Collado was responsible for therapist training. Weekly clinical supervision was provided 
by Ms. Collado and Ms. Long, both advanced graduate students who have received 
extensive training in implementing BA and supportive therapies. Spanish manuals for 
both conditions were used at all times to ensure standardization of treatment.  
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2.7. Therapist adherence, fidelity, and competence 
 
  Treatment integrity, fidelity, and competence were a priority. Therapists received 
extensive training and supervision. All therapy sessions except for five (due to logistical 
errors) were audiotaped. Therapy tapes were rated by an independent rater (e.g., a 
Spanish Speaking RA not working with the client from the pool of three study research 
assistants) to assess therapist adherence and competence with the treatment protocol, 
using separate rating checklists and scales developed by Ms. Collado for the SC and 
BATD conditions for 20% of audiorecorded sessions. Therapists also self-reported their 
adherence for each session across conditions. Ms. Collado listened to every session and 
provided feedback to each therapist in the weekly, two-hour supervision meeting.  
Therapists self-reported that they were completely adherent to SC and BATD. 
Independent rating indicated that therapists were strongly adherent to the respective 
treatments to which they were assigned. Therapists demonstrated a 96.7% adherence to 
BATD therapy. Deviations were due to not having enough time within the 60-minute 
treatment to discuss specific components of BATD. Any missed components of BATD 
were discussed during the following session. Adherence tests for SC were also high 
(97.4%) with the exception of four sessions in which there was one deviation noted. In 
two of these sessions, participants raised the possibility of engaging in activities to 
overcome depression (a topic closely related to BATD) and the therapist continued this 
discussion. In the remaining two sessions in which a deviation occurred, the therapist 
made a reference to participant values (a main component of BATD). All of these 
treatment divergences were discussed with the respective therapists individually and 
were discussed during group supervision.  
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2.8. Materials and Measures  
 
In line with our study aims, questionnaires were selected to assess five principal 
domains. The first domain focused on participants’ characteristics including their 
demographic information, English language proficiency, current antidepressant use, 
immigration status, acculturative stress, income, and depression treatment history. These 
variables were treated as covariates in the case that they were related to our main 
treatment outcomes (depression, activation, and/or contact with environmental 
reinforcement). To measure the second domain, we utilized a self-report assessment and 
a semi-structured clinical interview to identify individuals’ depressive symptomatology 
and MDD diagnosis, respectively for the study duration. The third domain of interest 
consisted of measuring the extent of clients’ activation and their receipt of positive 
reinforcement from the environment. To assess the fourth domain we examined 
treatment attendance. The fifth domain of assessment consisted of measuring clients’ 
attitudes toward treatment. Within this domain we explored clients’ perceived 
therapeutic alliance, treatment satisfaction, and stigma associated with depression 
treatment.  
Table 1 offers a summary of the questionnaires that were used, the domain that 
was assessed, and the time-point at which these were administered. 
Domain 1- Participant Characteristics 
 
General Information: A standard demographics questionnaire used at CAPER 
and also used in the preliminary trial was modified to include items regarding 
participants’ education, income, years of residence in the United States, depression 
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treatment history, level of English language proficiency, immigration status, and 
reason(s) for immigrating (if applicable). 
Multidimensional Acculturative Stress Inventory (MASI; Rodriguez et al., 2002): 
Originally created to measure acculturative stress from living in the United States for 
individuals of Mexican origin, the scale is comprised of four subscales including English 
Competency Pressures (7 items), Pressure to Acculturate (7 items), Pressure Against 
Acculturation (4 items), and Spanish Competency Pressures (7 items). Given the non-
applicability of the last subscale for the current sample, we only used the first three 
subscales. Higher scores indicate greater stress. The Spanish version of the questionnaire 
has achieved Cronbach alpha values ranging from .74 to .91. Cronbach’s alpha for the 
MASI in the current study was .73.  
Medication use: To determine study eligibility and the potential effect of 
pharmacotherapy or other medications on the results of the treatment, we collected 
information on participants’ medication use, including the names and length of use. 
Participants were excluded from the study if they were taking medication but did not 
demonstrate psychotropic stability as indicated by three or more months of consistent 
use. Two people in the study were taking medication for the treatment of depression 
over the course of treatment and follow-up.  
Domain 2- Depressive Symptomatology 
For diagnostic inclusion as well as to identify depressive mood variations 
through the study trial, we utilized the Beck Depression Inventory-II (BDI-II; Beck, 
Steer & Brown, 1996). The inventory consists of 21 items that assess severity of 
depressive symptomatology.
 
BDI cumulative scores range between 0 and 63; scores 
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ranging between 14 and 19 are indicative of mild depression, scores between 20 and 28 
are indicative of moderate depression, and scores of 29 or above are indicative of severe 
depression. The Spanish version of the BDI-II was developed by Sanz, Perdigón & 
Vázquez (2003) and was evaluated with a sample of 470 Spanish community adults. 
Internal consistency for the BDI-II in the current study ranged from .86 to .91 across all 
sessions and the one-month follow-up.  
Additionally, to establish an MDD diagnosis and evaluate remission rates, we 
administered the Structured Clinical Interview for DSM-IV (SCID-IV, non-patient 
version; First, Spitzer, Gibbon, & Williams, 1995). For the current study, specific 
modules of the SCID-IV were used to assess for: 1) primary affective disorders, 
including major depression and manic episodes, 2) substance use disorders, including 
abuse and dependence, 3) primary anxiety disorders, including panic disorder, 
generalized anxiety disorder, and posttraumatic stress disorder, and 4) and psychotic 
symptoms.  
Domain 3- Behavioral Activation and Reinforcement/Punishment Derived from the  
 Environment   
We utilized two different measures of activation in our study given purported 
differences between the constructs they are intended to assess: The Behavioral 
Activation for Depression Scale (BADS; Kanter, Mulick, Busch, Berlin, & Martell, 
2007) and the Reward Probability Index (RPI; Caravalho et al., 2011).  
The Behavioral Activation for Depression Scale (BADS; Kanter, Mulick, Busch, 
Berlin, & Martell, 2007) consists of 25 items and was designed to measure the extent to 
which individuals become more activated and less avoidant through the course of the 
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BA intervention. Among the questionnaire subscales are Activation, 
Avoidance/Rumination, Work/School Impairment, and Social Impairment. Given that 
examining participants’ activation levels through treatment course is highly relevant to 
our study hypotheses, we will examine increases in the total BADS scale as well as in the 
BADS Activation subscale specifically. The Activation subscale contains items related to 
the engagement in focused, goal-directed activities as well as to the completion of 
scheduled activities (Kanter et al., 2006) which allows examining activation changes 
while isolating impairment elicited by avoidance or rumination (also measured within 
the BADS). Items comprising this subscale include “I am content with the amount and 
types of things I did” and “I engaged in a wide and diverse array of activities.” The 
internal consistency of the Spanish version of the complete BADS scale has been 
reported at .80 and at .81 for the BADS Activation subscale when administered to a 
sample comprised of students at a Spanish university (Barraca, Pérez-Álvarez, & Bleda, 
2011). BADS’ internal consistency ranged from .86 to .91 across all sessions and the 
one-month follow-up.  
The Reward Probability Index (RPI; Carvalho. et al., in press) is a 20 item scale 
that was developed to assess availability of reinforcement in the environment. The total 
RPI consists of two subscales: 1) the Reward Probability Index, which includes items 
measuring the likelihood to which individuals are able to obtain reinforcement through 
instrumental behaviors, and 2) the Environmental Suppressors Index, consisting of items 
that describe the availability of aversive and unpleasant experiences in respondents’ 
environment (Caravalho et al., 2011). Total RPI score is calculated by adding scores of 
the items measuring Reward Probability Index with reversed scores of the items 
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measuring Environmental Suppressors. Internal consistency of the total RPI scale was α 
= .90 and the test-retest reliability r=.69 in the original validation study. Because there is 
no psychometric evaluation of a Spanish translation of the RPI, the team that translated 
the original BATD treatment into Spanish also translated this assessment tool. Ms. 
Collado was responsible for back-translating the items into English (please see Fouad & 
Bracken, 1986 for more information about this procedure). Discrepancies between the 
back-translation and the original version of the questionnaire were discussed among the 
parties and addressed. In the original validation study (Carvalho et al., 2011), 
psychometric properties of each subscale suggested a strong internal consistency 
(α = .82 - .90) as well as strong test–retest reliability (r = .83- r = .86) (Carvalho et al., 
2011). In the current study, the Cronbach’s alpha for the Spanish translation of the total 
RPI scale ranged between .77 and .81. Further, Cronbach’s alpha for the Reward 
Probability Index ranged between .76 and .95 and between .75 and .88 for the 
Environmental Suppressors Index across sessions.  
Our rationale for administering both the BADS and the RPI was based on the 
purported differences between the constructs they assess. Manos, Kanter and Busch 
(2010) indicated that the BADS measures frequency of activation, escape, and 
avoidance, whereas the RPI measures the probability of obtaining reinforcement through 
access to environmental rewards. Further, throughout the course of the preliminary study 
we conducted, we observed differing magnitudes between the correlations among our 
activation measures, which may support the argument that these questionnaires are 
tapping into different constructs; correlations ranged from .09 and .75 for the RPI and 
BADS, across our treatment sessions.  
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Domain 4- Treatment Adherence 
  Attendance: Session attendance was logged for every client. In addition, 
homework completion was verified and noted at each session.  
Domain 5- Attitudes toward Treatment 
To measure stigma-related concerns associated with depression treatment, 
participants completed the Stigma Checklist Questionnaire (Vega, Rodriguez & Ang, 
2009), which was specifically designed for use with low income Spanish speaking or 
bilingual primary care Latino patients. The questionnaire consists of 7 items designed to 
identify participants’ perceptions of others who have depression and take medication, as 
well as their fear of relatives learning that they are dealing with depression. The 
reliability of the scale has been reported at a Cronbach’s alpha of 0.69. The internal 
reliability of the SCQ in the current study ranged from .23 to .57. Because of these low 
reliabilities, we decided not to use the questionnaire in further analyses as had been 
previously planned.  
 The Therapeutic Alliance with Clinician Questionnaire (TAC; Neale & 
Rosenheck, 1995) assesses the strength of the therapeutic relationship using a 9-item 
Likert scale format. The Spanish version of the questionnaire (Bedregal, Paris, Jr., Añez, 
Shahar & Davidson, 2006) was evaluated with a sample predominantly comprised of 
depressed individuals and achieved high internal consistency (α = .96) and an item 
component correlation of 0.70. The authors concluded that the measure has both clinical 
and research utility. In the current study, alpha coefficients ranged from .94 to .97 across 
all sessions in which the TAC was administered.  
To elicit feedback about both treatments, we administered an in-house developed 
questionnaire every other session. Participants rated the treatments on a 1 to 6 Likert-type scale 
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across 9 items including “to what extent do you believe that this treatment has improved your 
depression/low mood?”, and “how valuable do you think this treatment would be for individuals 
who experience depressed/low mood?” The questionnaire contained one last item in which the 
participant was asked to rate the extent to which the treatment helped from 1 (“no help”) to 4 
meaning (“helped substantially”). This treatment satisfaction scale ranged from 10 to 58, with 
higher scores representing higher treatment satisfaction. Internal consistency ranged between .91 
and .96 across all of the sessions in which the CDS was administered.  
2.9. Design Considerations  
 
We made a number of choices that led to the current study design with the 
overarching goal of balancing internal validity and generalizability. First, we chose SC 
as a comparison group, following the recommendations of Chambless and Ollendick 
(2001), who outlined the benefits of a programmatic approach to treatment development 
research involving progressive stages for the evaluation of novel treatments. Although 
we considered the use of a waitlist control group, we believed that in a sample afflicted 
with MDD, the use of this comparison group would not be ethical.  Second, research has 
shown that Latino clients attribute depression to a lack of support (Cabassa, Lester & 
Zayas, 2007). As such, SC would provide an initial source of support to clients 
randomized to this condition.  
An additional design consideration surrounding the use of SC as a control 
treatment condition was that the use of the therapy could potentially limit our ability to 
detect significant differences. However, we believed that this concern was mitigated 
because activation and contact with positive environmental reward are targeted in 
BATD but not in SC. Thus, even if no statistically significant between-group effects 
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would be detected, the study could yield important information regarding within-group 
changes in activation and environmental reinforcement and their relation to depression. 
Despite the small sample of our pilot study (Collado-Rodriguez et al., 2013), we 
observed significant increases in activation and environmental reinforcement which 
corresponded to depression. Further, a within-subject analytic approach like HLM (see 
Data Analysis Plan) coupled with the frequency of assessment administration would 
increase our power to look at concurrent changes between BA proposed mechanisms 
and depression outcomes. Even in the case that statistically significant depression 
differences between groups were not detected, the data would provide important 
information regarding beneficial treatments for this underserved and underrepresented 
group. We also conducted a power analyses that suggested we had sufficient power to 
detect significant differences across conditions (see Sample Size Considerations). 
Similarly, we examined other outcomes (e.g., stigma, treatment satisfaction, therapeutic 
alliance), highly relevant to our sample of interest, which could provide important 
knowledge about the effect of BATD and SC on these treatment correlates. Although we 
considered examining these variables as potential mediators of the relationship between 
each treatment and decreases in depression, there was currently insufficient research in 
this area to support these analyses. Therefore, as a first step, we planned on examining 
differences on these key variables across the treatment conditions. Results from these 
analyses may lay the groundwork for an important future direction in a larger 
randomized controlled trial.  
Given that our decision to include SC as a treatment condition still generated 
ethical and safety concerns, we implemented an extensive safety protocol with which 
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research assistants and therapists were trained at length (see Protection of Participants 
below). In addition, participants were given the choice of receiving the other treatment 
to which they were not assigned after their participation in the study concluded. 
Fourth, we chose to exclude patients with co-occurring bipolar I, psychotic, and 
present substance dependence disorders, as these conditions would require alternative 
treatment approaches. For substance use disorders, we required that participants had no 
DSM-IV substance dependence diagnosis in the past six months. Participants with other 
Axis I comorbidity were not excluded to preserve a higher degree of generalizability.  
Fifth, we considered delivering the treatment in a group format which would 
increase cost-effectiveness of the treatment. However, we ultimately chose an individual 
format for two reasons. First, application of this work to community settings is crucial 
for generalizability and individual therapy is preferable for this reason given it is more 
commonly utilized in these settings. Second, our pilot data indicated that frequently 
changing work schedules would be particularly evident among our study population and 
therefore the relative flexibility of scheduling for individual sessions as compared to 
group sessions was seen as a considerable strength of the former for treatment 
attendance and retention through follow-up.  
Sixth, we strongly considered the assessment schedule for this study for our 
primary outcome variables. Although the frequency of questionnaires may appear 
burdensome, in line with a number of BATD-based studies ongoing in CAPER, we 
routinely administer this battery of measures in concert with treatment sessions. Thus, 
we strongly believe that at this stage, systematically assessing these highly relevant 
variables of interest would be able to provide a better understanding of how these factors 
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affect the course of both treatments. Consistent with preceding research examining 
treatment correlates among our sample of interest (e.g., Kanter et al., 2010; Muňoz & 
Mendelson, 2005), we considered that limiting the administration of these questionnaires 
to three times through the course was appropriate.   
2.10. Protection of Participants 
 
Given that the decision to include a SC condition as a depression treatment 
generated concerns, we incorporated a Data Safety Monitoring Board (DSMB) 
specifically to monitor and ensure participants’ safety through the course of treatment. 
Members of the DSMB included five independent researchers who all had extensive 
experience in treatment research with Behavioral Activation Treatment for Depression 
(BATD) and depression treatment research in general. These individuals were involved 
in the project as DSMB members in order to guarantee objectivity regarding 
participants’ safety, study conduct, and recommendations concerning the continuation or 
modification of the project’s safety protocol. Any potential issues (during screening or 
during study participation) were discussed immediately over the telephone with the 
DSMB. However, no potential safety issues were detected at any stage of the study. 
Participants were closely monitored during the duration of the trial. Overall, the safety 
procedures were as follows: 
At every appointment, participants completed the BDI-II which contains 
questions about suicidal ideation and intent. If the suicidality item would have been 
endorsed at any time (e.g., “I would like to kill myself” or “I would kill myself if I had 
the chance”), our primary goal was to ensure participants’ safety. If a participant 
reported elevated suicidality, a risk assessment protocol would have been initiated. 
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Every research assistant involved in the study was trained in these procedures following 
an already-established protocol for depression treatment development projects 
conducted at CAPER and Ms. Collado’s previous work with depressed Spanish-
speaking Latinos to ensure participants’ safety.  
First, a Spanish version of the MSSI (Modified Scale for Suicidal Ideation) 
which was translated in the center for the initial pilot study would have been 
administered to assess for severity of suicidal ideation. Prior to administering the MSSI 
the PI and client’s therapist would have been notified. Immediately after conducting the 
MSSI, the RA would have informed the therapist of the results. The therapist would then 
engage in an honest discussion with the client about his or her likelihood of carrying out 
suicide. The therapist would also conduct a lethality risk assessment and draw a contract 
with the client that he or she would not make any attempts to carry out the plans. The 
outcome of the discussion as well as the therapist’s impressions would involve the RA to 
document this information. If the client indicated that he/she was in imminent danger (in 
or out of session), the appropriate authorities would be notified. Ms. Collado, Drs. 
Lejuez, MacPherson (Dissertation Co-Chairs) and the members of the DSMB would 
then be informed of the outcome of the MSSI conducted by the RA and the impressions 
of the therapist. A conference call discussing relevant details would have then taken 
place with all of the DSMB members. DSMB members would have provided a future 
plan to ensure the client’s safety.  
For cases of suicidal ideation, a similar protocol was utilized. If suicidal ideation 
would be indicated, a lethality risk assessment would be put in place. At no point during 
the study, was the implementation of these procedures necessary. Please see participant 
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safety procedures along with lethality risk assessment and reasons for living contract in 
Appendix 1.  Please see Figure 1 for a depiction of these procedures.  
2.11. Sample Size Considerations 
 
 We based our sample size needs on effects observed in the literature, including 
other treatment studies, and by making informed decisions about the magnitude of 
effects of BATD in this population that would likely be of clinical significance. For the 
primary outcome that BATD would result in greater reductions in depressive symptoms 
(Aim 1), we calculated the sample size required based on a recent meta-analysis 
conducted that examined the effect size of BA relative to control conditions (Ekers, 
Richards & Gilbody, 2008)  and on a treatment study that compared CBT to an active 
treatment condition (Interpersonal Psychotherapy) conducted by Rosselló, Bernal and 
Rivera-Medina (2008) in a Spanish-speaking Latino sample which yielded effect sizes 
of .43 and .74, respectively, indicating medium to large effect sizes. Conservatively, our 
proposed sample size of 23 in each cell is well within that suggested by a power analysis 
using these two reported effect sizes to allow for a power of .80 using an alpha of .05 
(Cohen, 1988).Our sample size also follows Rounsaville and colleagues’ (2001) 
recommendations of including 15-30 subjects per cell in Stage 1b trials.  
2.12. Data Analysis Plan 
 
Hierarchical Linear Modeling (HLM; Raudenbush & Bryk, 2002) were used to 
examine within-subject change of depression (first aim) activation and reward derived 
from the environment (second aim) over the course of treatment. The nature of HLM 
analyses allowed us to control for baseline scores of each measure, include multiple 
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measurement points while accommodating missing data, examine individual change 
over time in outcomes, and include the average change and the individual variation 
around this average change. We specified all of our HLM Level-1 intercepts as random, 
given that we expected first session depressive symptomatology, activation, and 
availability of reinforcement in the environment to differ across our participants. We 
centered all variables of interest (except for time) around the grand mean of respective 
scores to avoid multicollinearity. Centering variables also allowed us to determine the 
impact of each individual's relative shift from their own mean weekly scores on these 
measures. Planned covariates in these analyses included recruitment method, English 
language proficiency level, assigned therapist, education, age, baseline levels of 
depressive symptoms as well as the main effect of treatment condition and the linear 
effect of time. Inclusion of the time by treatment condition interaction would indicate 
the extent to which treatment differences are more or less pronounced early versus later 
across treatment sessions. Categorical rates of remission of MDD (also evaluated within 
Aim 1) as indicated by the SCID-IV were examined across treatment conditions using 
the Cochran-Mantel-Haenszel test.  
To examine the correspondence between increases in activation and 
environmental reinforcement with depression (examined within the second aim), we also 
used HLM to examine correspondence of these variables over time. We examined 
correspondence between depression with activation and environmental reinforcement 
only if these study variables of interest demonstrated change over time. These models 
included the aforementioned covariates in addition to including activation and 
environmental reinforcement as time-varying predictors of depression, the main effect of 
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treatment condition, the linear effect of time, a two-way interaction between treatment 
condition and the linear effect of time, a two-way interaction between the linear effect of 
time by activation or environmental reward, and a three way interaction of time by 
treatment condition by activation or environmental reward. Because of the difficulty in 
attributing causality between variables assessed at the same time point, we also 
conducted analyses predicting depression with environmental reward and activation 
assessed at the previous time point as time-varying covariates (please see Figure 1 
depicting the concurrent and lagged analyses). In this model, for example, RPI score at 
session 5 was specified as predicting BDI –II at session 6. These lagged analyses 
indicate whether the predictors precede changes in depressive symptomatology 
consistent with the BATD framework that activation and environmental reward are 
expected to increase before depression decreases.  
To examine more closely the effects of treatment on attendance (third aim), we 
conducted a Cox proportional hazards survival analysis predicting sessions to attrition. 
This allowed us to examine the extent to which BATD was able to increase the latency 
to treatment attrition.  
To test our remaining hypotheses within the third aim, we conducted t-tests 
examining differences between BATD and SC in treatment satisfaction and therapeutic 
alliance at each session these correlates were examined.  
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A total of 110 callers contacted CAPER expressing interest in our study. Out of 
those callers, 12 could not be re-contacted after they left a message on the study 
voicemail. At least five attempts were made by study staff to contact these potential 
participants, with messages left at each contact attempt. Out of the 98 remaining callers 
that were screened, 22 were excluded from participation based on our study criteria. In 
addition, 12 callers were not interested in the study after they were provided with 
information about the project. Of the remaining 64 potential participants, 16 did not 
show for the baseline appointment. Although several attempts were made to reschedule 
these callers through numerous telephone calls, these individuals did not show for 
subsequent appointments. Of the 48 individuals that attended the baseline appointment, 
two were deemed ineligible. The 46 participants remaining participants were enrolled in 
the study within eight months. Please see Figure 2 for a Consort Diagram for the study.  
Participants enrolled in the study represented the following countries: El 
Salvador (n = 13), Guatemala (n = 7), Honduras (n = 6), Mexico (n = 6), Colombia (n = 
4), Peru (n = 2), Chile (n = 2), Nicaragua (n = 1), Paraguay (n = 1), Dominican Republic 
(n = 1), Costa Rica (n = 1),  Ecuador (n = 1) and the United States (n = 1).  
Participants reported having lived in the United States for a mean of 4.07 years 
(SD = 2.69). Participants’ ages ranged from 18 to 74 and their mean age was 35.91 years 
(SD = 13.80). The sample consisted of 39 females and seven males. The number of 
males recruited was proportionally lower in this current trial (15%) relative to the initial 
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pilot trial (30%) that we conducted (Collado et al., 2013)  Thirty-seven percent of 
participants reported earning a yearly income of less than $14,999; 41% indicated being 
employed full time, 24% reported being unemployed, and 11% reported being employed 
part-time. Participants’ mean education was a 10.93 grade level (SD = 3.74). There was 
wide variability in the sample’s English speaking and reading proficiency. The majority 
of participants indicated that they were able to understand “a little” spoken and written 
English. Twenty-two percent and 28% indicated that they were able to understand 
spoken English and written English, respectively.  Approximately 13% of the sample 
self-reported that they were not able to understand spoken and written English. In terms 
of marital status, 28% of participants indicated they were married and 37% reported 
being single. Most (91%) indicated having immediate family in the U.S. Table 2 
summarizes baseline demographic characteristics for the complete sample and across the 
SC and BATD condition.    
2.2. Clinical Characteristics at Treatment Onset 
 
To assess for psychiatric disorders, we administered the SCID-IV. Participants 
demonstrated high levels of comorbidity. Other than meeting criteria for MDD, 43.5% 
of participants met criteria for Dysthymia, 24% for Panic Disorder, 28% for 
Posttraumatic Stress Disorder, and 65% for Generalized Anxiety Disorder. In terms of 
participants’ depressive symptomatology, the sample’s mean BDI-II score at the first 
assessment was 29.70 (SD = 10.36), indicating severe depression. Participants’ total 
mean activation score as indexed by the BADS, was 54.13 (SD = 23.97) on a 0 to 150 
scale. The mean score of the BADS Activation subscale was 20.28 (SD = 9.82) out of 42, 
with higher scores indicating more activation. The total mean reinforcement derived 
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from the environment assessed by the RPI was 47.56 (SD = 8.82) in a 0 to 80 scale, with 
higher RPI scores indexing higher access to environmental reward. The baseline mean 
score for Environmental Suppressors was 18.91 (SD = 4.97) with higher scores 
representing a higher likelihood of punishment derived from the environment and 28.64 
(SD = 6.09) for Reward Probability, with higher scores indicating a higher likelihood of 
reward obtained from the environment. The maximum score for each Index is 40. 
Finally, participants obtained a mean score of 26.28 (SD = 17.25) on the MASI scale out 
of a possible score of 95 indicating low levels of acculturative stress overall.  
Only two participants reported taking antidepressants at baseline for at least 1 
year. These participants indicated that they continued their medication use throughout 
the course of the study and the one-month follow-up. In addition, 28% of participants 
indicated that they had received treatment for depression in the past. Please see Table 3 
for a complete summary of participants’ clinical characteristics as part of the complete 
sample and in each condition.  Neither demographic nor clinical characteristics showed 
significant between-group differences (ps > 0.20). In addition, one-month follow-up 
numbers were not significantly different between BATD (n = 15) and SC (n = 11) (p = 
0.24).  
Covariates 
 We controlled for education in models containing depressive symptomatology as 
a result of their significant association over time (p = 0.01). Although there were no-
between group differences in demographic or clinical characteristics, we also controlled 
for therapist assigned to participants given the wide range in therapists’ education and 
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training. The nature of HLM analyses also allowed us to control for baseline scores of 
each of the outcome variables when examining their change over time.  
2.3. Aim 1 – Results 
 
Depressive Symptomatology: Depressive symptomatology as measured by the 
BDI-II decreased over time over the course of treatment (β = -2.16, SE = 0.21, p < 
0.001). Further, the interaction between treatment condition and the linear effect of time 
was significant (β = -0.59, SE = 0.28, p = 0.037), indicating that participants assigned to 
BATD evidenced greater reductions in depressive symptoms over time relative to those 
assigned to SC. Please see Figure 4 for the depiction of these results.   
MDD Remission: Categorical rates of remission of MDD were examined across 
treatment conditions using the Cochran-Mantel-Haenszel test. The results of this test 
indicated that at end-of-treatment participants showed a significant effect in favor of 
BATD (χ2 (1) = 6.52, p = 0.01; 14 participants (93.3% of the 15 who completed 
treatment) in the BATD condition showed remission of MDD relative to 6 participants 
(50% of the 12 who completed treatment) in SC.  Please see Figure 5 for a depiction of 
these results.  
2.4. Aim 2- Results 
 
For the second aim, we examined changes in the proposed mechanisms of BATD 
and hypothesized reductions in depressive symptomology, including activity level (using 
the total BADS scale and BADS Activation subscale) and environmental rewards and 
punishment (using the total RPI scale, the RPI-reward probability subscale, and the RPI-
environmental suppressors subscale). We examined the interaction of time by condition 
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of each of these constructs. For our concurrent and lagged analyses, we examined three-
way interactions between time, condition, and proposed mechanism of change only in 
cases in which lower-order interactions were significant. Therapist assignment was 
included as a covariate.  
Activity Level: Activity level as measured by the total BADS scale showed a 
significant linear effect of time suggesting that this construct increased over the course 
of treatment (β = 3.88, SE = 0.61, p < 0.001). The interaction between treatment 
condition and the linear effect of time was not significant (β = 0.67, SE = 0.82, p = 
0.41), indicating that there were no differential effects of treatment across time in 
activity level.  
As mentioned previously, the BADS scale is comprised of an activation subscale 
that allows the examination of activation changes while isolating impairment elicited by 
avoidance or rumination (also measured within the BADS). Activity level measured by 
the BADS Activation subscale showed a significant linear effect of time suggesting that 
this construct increased over the course of treatment (β = 0.61, SE = 0.25, p = 0.02). 
Further, the interaction between treatment condition and the linear effect of time was 
also significant (β = 0.83, SE = 0.28, p = 0.01), showing that those who were 
randomized to the BATD condition reported greater activity level over time relative to 
those who were assigned to the SC condition. Please see Figure 6 for a depiction of this 
interaction.  
Environmental Reward and Suppressors: To examine changes in environmental 
reward and punishment across treatment, we utilized the total RPI scale, which includes 
two different subscales: the Reward Probability subscale and the Environmental 
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Suppressors (i.e., punishment) subscale. As part of this aim, we examined the total RPI 
scale, and each of its subscales independently.  Reward probability as indexed by the 
total RPI scale showed a significant linear effect of time (β = 0.79, SE = 0.16, p < 0.001) 
suggesting that this construct increased over the course of treatment. The interaction 
between treatment condition and the linear effect of time was significant (β = 0.46, SE = 
0.23, p = 0.05), demonstrating that participants randomized to BATD showed greater 
increases in the construct over time relative to participants who received the SC 
intervention. Please see Figure 7 for a depiction of this interaction.  
There was also a significant linear increase over time for environmental reward 
as measured by RPI’s Reward Probability subscale (β = 0.47, SE = 0.08, p < 0.001). 
The interaction between treatment condition and the linear effect of time was not 
significant (β = 0.27, SE = 0.15, p = 0.08), showing that participants randomized to 
BATD showed similar increases in the construct over time in comparison to those who 
were randomized to SC.  
Environmental punishment showed a linear effect of time (β = 0.32, SE = 0.100, 
p = 0.003) such that over the course of treatment, the construct decreased in the entire 
sample. The interaction between treatment condition and the linear effect of time was 
non-significant, indicating no differential effects of treatment across time (β = 0.12, SE = 
0.16, p = 0.47). Please see Table 4 for a summary of changes over time in clinical 
variables of interest.  
Also as part of Aim 2, we tested the correspondence of the proposed mechanisms 
of BATD and depression concurrently and prospectively in models 1 and 2, respectively. 
We outline the results below: 
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Model 1- Concurrence of Activity Level and Environmental Reward with Depression 
over Time 
 Model 1 tested the extent to which these proposed mechanisms at one session 
corresponded simultaneously with depressive symptomatology at the same session over 
time (i.e., activity level at session 1 with depression at session 1, activity level at session 
2 with depression at session 2, and so forth).  
 Concurrence of Activity Level and Depressive Symptomatology: Activity level 
as measured by the total BADS scale and depressive symptomatology, measured by the 
BDI-II did not correspond simultaneously over time (p = 0.77), indicating that these 
constructs did not change together and at the same time. We also examined activity level 
as indexed by the BADS Activation subscale. These results did not show a relation 
between activation and depression over time (p = 0.08). As such, three-way interactions 
between time, activity level, and condition were not performed given non-significance 
of the lower-order interactions.   
Concurrence of Environmental Reward and Depressive Symptomatology: 
Environmental reward measured by the total RPI scale and depressive symptomatology 
did not correspond simultaneously over time (p = 0.67) indicating that environmental 
reward and depression did not change together. We also examined environmental reward 
and punishment as indexed by RPI’s Reward Probability and Environmental 
Suppressors subscales, respectively. These results indicated no relationship between 
these two constructs and depression (ps > 0.21). Three-way interactions including time, 
condition and environmental reward or punishment were not performed given that the 
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lower-order interactions were not significant. Please see Table 5 for a summary of these 
results.  
Model 2: Lagged Analyses between Activation and Environmental Reward with 
depression 
Our second analytic model consisted of lagging activation and environmental 
reward and punishment to test whether these constructs corresponded to depressive 
symptomatology at a subsequent session; that is, whether activation and contact with 
environmental reinforcement preceded depressive symptoms over the course of 
treatment (i.e., reward probability at session 1 with depressive symptoms at session 2, 
reward probability at session 2, depressive symptoms at session 3, etc.) 
Lagged Activation Level and Depressive Symptomatology: Lagged analyses 
indicated that activity level measured by the total BADS scale did not precede depressive 
symptomatology over time (p = 0.92). Similarly, the interaction of time by activity level 
measured by BADS- Activation subscale was not significant (p = 0.16) suggesting that 
activity level did not precede changes in depression symptomatology.  
Lagged Analyses – Environmental Reward and Depressive Symptomatology: 
Lagged analyses indicated that higher total environmental reward did not precede 
decreases in depression in the study sample (p = 0.07). Results also indicated RPI’s 
Reward Probability and Environmental Suppressors did not precede changes in 
depression (ps > 0.26). Please see Table 6 for a summary of these results.  






Averaging across clients, a mean of 7.35 (SD = 3.65) sessions were completed 
over a mean of 9.02 weeks (SD = 4.58). Participants randomized to BATD completed a 
mean of 7.96 sessions (SD = 3.36) in an average of 9.65 weeks (SD = 4.68). Individuals 
assigned to the SC condition completed a mean of 6.74 sessions (SD = 3.86) in an 
average of 8.39 weeks (SD = 4.50). There were no significant differences between 
conditions in terms of sessions completed (p = 0.26) or weeks until treatment was 
completed (p = 0.36).  
Three participants randomized to SC and two participants in BATD completed 
only one treatment session. Five participants randomized to SC and three participants in 
BATD completed between two to four sessions. Three participants randomized to SC as 
well as to BA completed between 5 and 8 sessions of treatment. Twelve participants 
assigned to SC and 15 participants assigned to BATD completed all 10 sessions of 
treatment. Independent samples t-test did not show SC or BATD differences in rates of 
treatment completion (p = 0.38). Please see Figure 2 for a breakdown of sessions 
completed for each session.  
Cox proportional hazards survival analysis was also used to predict BATD and 
SC latency to treatment attrition. The model included baseline symptoms of depression 
(BDI-II) and therapist assignment as covariates. The model was not significant (χ2 (11) = 
14.65, p = 0.20, see Figure 9) suggesting that BATD and SC were equal in their effect 
on treatment completion after adjustment for the relevant covariates included in the 
model. Please see Figure 9, which depicts these results.  
An additional measure of treatment adherence considered in the current study 
was homework completion. Among participants who completed more than one session 
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in either treatment (N= 40), homework completion for BATD participants was 75.18% 
and 63.35% for SC participants. Homework completion was not significantly different 
between the SC and the BATD (F (1, 37) = 1.63; p = 0.21) after statistically controlling 
for completed sessions. Altogether, treatment adherence was not significantly different 
between SC and BATD.  
Treatment Satisfaction  
 For Aim 3, we examined treatment satisfaction using HLM analyses. Results 
suggested that treatment satisfaction increased over time (β = 0.59, SE = 0.18, p = 
0.002), but did not differ by condition (p = 0.17).  
Therapeutic Alliance  
 Also within Aim 3, we examined differences in therapeutic alliance over time 
and between conditions. HLM analyses suggested that therapeutic alliance increased 
over time (β = 1.02, SE = 0.19, p < 0.001) but was not different for participants assigned 
to BATD and SC (p = 0.91).   
Maintenance of Clinical Gains over a One-Month Follow-up  
 
We sought to examine whether improvements made during the course of 
treatment were sustained from the last treatment session to the one-month follow-up. 
Toward this end, we conducted paired t-tests and expected to find that clinical gains 
would be sustained, particularly for the BATD condition. A total of 15 people 
randomized to BATD and 11 people randomized to SC completed the one-month 
follow-up. Paired t-tests between end-of-treatment and the one-month follow-up clinical 
variables were not statistically significant (all ps > 0.06), indicating that clinical gains 
were sustained across all clinical variables of interest for both the BATD and SC 
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condition. There were also no significant changes in remission rates between both 
conditions from end of treatment to the follow-up period (p = 1.00), suggesting that 
MDD diagnosis or remission did not change in this time frame. Given that MDD rates 
remained consistent between conditions, a higher percentage of BATD participants 
evidenced remission relative to those in the SC (χ2 (1) = 6.52, p = 0.01). Please see 




Chapter 4: Discussion 
 
4.1 Summary of Main Findings 
 
The current RCT (N = 46) evaluated the efficacy of BATD against a time-
matched SC protocol among depressed Latinos with Spanish-speaking preference. Our 
study aims aligned with an effort to expand the mental health treatment literature for this 
much underserved US population. The current study builds on the results of a small 
open-label trial (Collado et al., 2014) that demonstrated significant clinical gains over 
the course of BATD for a similar target group in the following ways: 1) inclusion of a 
contact time and homework-matched control condition (SC), 2) examination of the 
effect of treatment on proposed BATD mechanisms of change (i.e., environmental 
reward and activity level), 3) an increase in sample size to examine between-treatment 
differences and to increase generalizability of results, and 4) inclusion of MDD as a 
criterion for eligibility. Specific outcomes of interest in the comparison of the two 
treatments groups were a) depressive symptomatology over time and MDD remission; 
b) environmental reward and activity level; and c) treatment satisfaction, therapeutic 
alliance, and treatment adherence.  
Aim 1: Between-Group Changes in Depression   
As part of Aim 1, we had hypothesized that participants randomized to BATD 
would evidence greater reductions in depressive symptoms. Our results were consistent 
with this hypothesis. In our trial, participants who completed BATD reduced their BDI 
depression scores from a baseline average of 30 (indicating severe depression) to an 
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average of 10 at the last treatment session (signaling minimal depression). This 
symptom reduction compared favorably to what has been reported in other trials among  
depressed Latinos who completed empirically-supported treatments, such as CBT (e.g., 
Organista et al., 1994; Miranda et al., 2003; Reyes, Verna, Bernal & Huertas, 2002) and 
Interpersonal Therapy (Spinelli & Endiccot, 2003). Furthermore, the reduction of 
depression scores for participants in this 10-session BA treatment study fared favorably 
with those observed in other studies (e.g., Gawrysiak, Nicholas & Hopko, 2009; 
Dimidjian et al., 2006). Altogether, these results support the efficacy of BATD as a 
treatment for depression in depressed Spanish-speaking Latinos.  Study outcomes also 
suggested that participants who were enrolled into BATD had a higher percentage 
remission of MDD relative to participants randomized to the SC condition throughout 
treatment course and at the one-month follow-up assessment. These findings were 
consistent with our Aim 1 hypothesis. The current RCT is among the few treatment 
research studies with U.S. Latinos that have included MDD as an eligibility criterion 
(e.g., Miranda et al., 2003; Reyes et al., 2002; Spinelli et al., 2003; Comas-Diaz, 1981) 
and the first that has assessed MDD at treatment conclusion and at follow-up.    
As part of our study aims, we also examined the extent to which clinical gains 
were sustained through the one-month follow-up in both treatment conditions. Clinical 
gains were maintained for both SC and BATD participants. One important finding to 
note, is that clinical gains were observed during active treatment duration and were no 
different during the follow-up. This stresses the importance of striving for MDD 
remission prior to treatment conclusion.  
Aim 2: Between-Group Changes in Clinical Constructs  
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 For the second aim, we hypothesized that over the course of treatment, 
participants assigned to BATD would evidence greater increases in activity level and 
contact with environmental reward relative to those assigned to the SC condition. 
Consistent with our predictions and with the results from the initial BATD open-label 
trial, results indicated that the BADS Activity level subscale and RPI’s total 
Environmental Reward scale showed greater increases over time among BATD relative 
to SC participants. Altogether, more pronounced changes in the BADS-Activation 
subscale and the total RPI scale among BATD relative to SC participants suggests that 
the treatment was effective in increasing these constructs over time. 
The finding that activity level measured by the BADS Activation subscale 
changed, but not the total BADS scale, may reflect that other domains measured by the 
total scale (i.e., Avoidance/Rumination, Work/School Impairment, and Social 
Impairment) are not as directly relevant for a treatment that is more focused on helping 
clients to add valued activities into their lives as opposed other aspects of activation such 
as rumination and life impairment which may be addressed equally well by SC and 
BATD.  
As part of Aim 2, we also examined concurrent and prospective associations 
between depressive symptoms with activity and environmental reward. Our results did 
not support our hypotheses about the timing of these processes. Specifically, 
environmental reward and activation did not co-occur with or precede depressive 
symptoms. The lack of relation between these constructs has also been reported in two 
recent trials (Ryba, Lejuez & Hopko, 2014; Hershenberg, Paulson, Gros & Acierno, 
2014). Both of these trials indicated that participants who received BATD increased the 
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activities that they completed over time, yet these changes were not systematically 
related to depressive symptomatology. This research combined with findings from the 
current study, suggest that the relationship between depression and activation may be 
more complex than previously hypothesized. In our trial, we conceive that one possible 
explanation for the lack of relation between activation and depressive symptomatology 
is that these variables may not shift together or do so from one week to the next in a 
consistent manner.   
Aim 3: Between-Group Therapeutic Alliance, Adherence, and Satisfaction  
Finally, for Aim 3, we expected that relative to participants assigned to the SC 
condition, participants randomized to BATD would report higher treatment satisfaction, 
greater therapeutic alliance, and greater treatment retention. Our analyses did not support 
our Aim 3 hypotheses.  
Moreover, while future work should consider the impact of BATD on these 
important therapeutic variables, the current results can be interpreted to support that the 
changes that we observed in depression, activity level, and environmental reinforcement 
are due to the treatment content of BATD and not to non-treatment specific variables 
that have generally shown to strongly relate to clinical gains (e.g., Chatoor & Kurpnick, 
2001). Retention for both conditions, participant completion of homework, number of 
sessions completed, and latency to attrition were not different between conditions. As 
such, concerns about investigator and therapist bias toward BATD are somewhat 
mitigated as a result of these findings.  




Following Carroll and Nuro’s (2002) suggestions for a sequential model for 
psychotherapy manual development and following positive results of an open-label trial, 
the current study consisted of a RCT with 46 participants. A first limitation of the study, 
is its relatively small sample size which not only could have prevented the detection of 
potentially significant relationships between depressive symptomatology and activation 
and environmental reward in the current study, but could also limit the generalizability 
of our results. For example, the interaction between treatment condition and the linear 
effect of time was trending significance for RPI’s Reward Probability subscale (p = 
0.08), as was our test of simultaneous correspondence between environmental reward 
measured by the total RPI scale and depressive symptomatology (p = 0.07). Therefore, it 
is important that future research recruit a larger sample size to confirm current results. A 
small sample size also raises the concern of limited generalizability to the greater Latino 
population given that Latinos in the United States are a very heterogeneous group. 
Another factor that could potentially limit the generalizability of our results are the high 
levels of comorbidity that characterized our sample (65% met criteria for Generalized 
Anxiety Disorder, 25% for Posttraumatic Stress Disorder, 24% for Panic Disorder, and 
44% for Double Depression defined as co-occurring MDD and Dysthymia). This 
comorbidity may reflect the clinical severity of this sample as well as well as the need 
for treatments for U.S. Latinos with reported Spanish language preference.  Further, it is 
uncertain whether the high comorbidity of our sample could have impacted the observed 
clinical improvements. Both participants enrolled in SC and BATD evidenced 
improvements in all clinical domains assessed in this treatment study.  
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A second important limitation inherent to efficacy trials, is the wide range of 
therapist expertise in this trial. Although randomization and therapist training and 
supervision in the principles of BATD and SC could assuage this concern, the 
significant difference in levels of clinical psychology training differed greatly, which 
could have decreased the efficacy of the treatments. However, the discrepancy in 
training could also be considered a strength of the trial. Most therapists (n = 5) had only 
received training in SC and BATD, which could have resulted in the high treatment 
adherence rates. In addition, therapists’ novice status underscores that relative ease and 
feasibility by which BATD and SC may be provided. This is perceived as a great 
advantage given that the literature underscores the limited availability of trained 
Spanish-speaking therapy providers. Given the limited time and training needed to 
implement this treatment, it appears ideal for an underserved population in immediate 
need of depression care.   
Third, the weekly administration of questionnaires may have been too proximal 
to capture perceived environmental rewards or activity engagement, which may be 
slower to occur than overt behavior change. With a larger sample size, future studies 
may consider utilizing a dual latent growth curve modeling approach to predict the slope 
of depressive symptoms over time with the slope of BATD treatment mechanisms (e.g., 
activity level or environmental reward). Future work is also warranted with the goal of 
identifying mechanisms of BATD that contribute to reduced depressive symptoms, 
including avoidance (e.g. Hershenberg, 2014); testing these hypotheses will require 
more complex analyses of mediation, which were unable to be conducted in the current 
study given the small sample size.   
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Fourth, the RPI and BADS (as well as each of these measures’ subscales) have 
not been tested or validated in Latinos with Spanish-speaking preference. The translation 
of the RPI was conducted internally for use in this study. Therefore, it is questionable 
whether this measure lacking psychometric evaluation in our sample and language of 
interest accurately reflects the factors proposed by Carvalho and colleagues (2011). 
Similarly, the BADS Spanish translation has been evaluated in a sample of university 
Spanish students, a sample that may not only differ culturally from our current sample, 
but also in terms of participants’ socio-economic level. Therefore, caution is suggested 
when interpreting these results. Psychometric tests of these measures are warranted in 
future studies in our sample of interest with a specific goal of examining these constructs 
as they relate to depression.  
Fifth, the study used SC as the control condition. Future research may consider 
utilizing an empirically-supported treatment as a comparison group. Despite the lack of 
evidence base for the intervention, it was well-received by study participants as 
indicated by high treatment satisfaction scores and high adherence rates (relative to the 
clinical research literature among this population). Furthermore, given that the SC 
condition was consistent with “desahogo” which is the frequently reported expectation 
among Latinos that therapeutic improvement is caused by relief through venting or 
getting things off one’s chest, we believe that this was an optimal comparison therapy 
for this stage of treatment evaluation. 
Altogether, there exist numerous limitations and opportunities to expand upon 
and enhance this line of research to further establish the efficacy BATD in improving 
depression (along with levels of activation and contact with environmental 
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reinforcement) among US Latinos with Spanish language preference. Despite these 
limitations however, study findings continue to support the promise of BATD as an 
efficacious, acceptable treatment for this underserved, understudied group in high need 
of depression mental health services.  
To our knowledge, this constitutes the first effort towards conducting an RCT 
comparing a behavioral intervention and a well-defined, manualized SC condition in a 
sample of depressed Spanish-speaking Latinos in the US with Spanish language 
preference. This group has been historically under-represented in both clinical and 
research samples, which has prevented drawing conclusions about the efficacy of 
psychotherapeutic treatments for depression for this population. Together, the increasing 
Latino population, the elevated MDD rates among Latinos with a Spanish-speaking 
language preference, high attrition rates, and suboptimal treatment gains reported in 
previous depression treatment studies, make the evaluation of BATD in this group a 
pressing need. Therefore, the present study contributes to a scarce yet much needed 
evidence base and it sets the stage for a larger RCT that is able to examine BATD 
against an empirically-supported treatment, examine additional moderators of treatment, 





Schedule of Questionnaire Administration 
 
Note. SCID-IV; BDI-II= Beck Depression Inventory, 2nd Edition; BADS = Behavioral Activation 
Depression Scale; RPI= Reward Probability Index Scale; TAC = Therapeutic Alliance with 
Clinical Scale. *Questionnaire was not included as part of our analyses as a result of 
administration error. **Questionnaire was not included as part of our analyses as a result of 
low internal consistency. 
 




Domain 1: Participant Characteristics  
Demographics  X                    
Acculturative 
Stress X                   
 
Other Med / 
Treatment Use X 




Domain 2: Depressive Symptomatology  
SCID-IV 
Modules X                 X 
X 
BDI-II X X X X X X X X X X X 
Domain 3: Behavioral Activation and Reinforcement Derived from the Environment  
BADS X X X X X X X X X X X 
RPI X X X X X X X X X X X 
Domain 5: Attitudes Toward Treatment  
Stigma 
Checklist**  X   X   X  X 
 
TAC  X   X   X  X X 
Treatment 











Overall Sample   BATD   SC   
            
M SD %   M SD %   M SD %                p 










   
83 
   
87 0.68 














Total Annual Income     
 
       
0.44 
     <$14,999   37    
45 
   
47 
 $15,000- $29,999   22    
20 
   
35 
 $30,000- $44,999   17    
25 
   
18 
 $45,000- $59, 999   4    
10 
   
0 
 Employment Status    
 
       
0.62 
    Employed half-time   11    
50 
   
36 
     Employed full-time   41    
9 
   
14 
 Marital Status    
 
       
0.91 
    Single/never married   37    
44 
   
35 
     Married   28    
30 
   
30 
     Divorced   13    
13 
   
15 
     Other   15    
13 
   
20 
 Immigration Status    
 
       
0.34 
    Permanent Resident   22    
18 
   
27 
     Undocumented   41    
36 
   
50 
     Citizen   17    
23 
   
13 
     Other   16    
23 
   
10 
 Immediate Family in the 
U.S. (yes)   91  
  
86 
   
91 0.60 
Able to Understand 
Spoken English   
 
 





   
30 
   
13 
 No    13    
13 
   
13 
 A little    65    
57 
   
74 
 Able to Understand 
Written English   
 
 
       
0.43 
Yes   28    
35 
   
22 
 No    20  
  
13 
   
26 




            Comparisons of Baseline Clinical Characteristics Variables Across Treatment Conditions 
                            
Clinical Characteristic Overall Sample 
 
BATD   SC   
               M SD %   M SD %   M SD % p 
             DSM-IV-TR Psychiatric 
Diagnosis     
            Dysthymia   44    
39 
   
48 0.55 
    Panic Disorder   24    
22 
   
26 0.73 
    Posttraumatic Stress   
    Disorder   28  
  
35 
   
22 0.33 
    Generalized Anxiety  
    Disorder   65  
  
74 
   
57 0.22 
Ever received treatment for 
depression (yes)   28  
  
36 
   
22 0.28 














    Reward Probability   





    Environmental   
    Suppressors subscale 
score 










    BADS-Activation   
    subscale score 20.28 9.82     19.17 7.62     21.39 11.70   0.45 
Note.  BATD: Behavioral Activation Treatment for Depression; SC: Supportive Counseling; DSM-IV-
TR: Diagnostic Statistical Manual, 4th Edition- Text Revised; MASI: Multidimensional Acculturative 
Stress Index; BDI: Beck Depression Inventory; RPI: Reward Probability Index; BADS: Behavioral 






HLM Primary Analyses- Changes over Time in Clinically-Significant Variables 
 
Predicted Variable and Fixed Effects Β SE T 
 
P 
     
     
BDI     
     Intercept 29.605 1.629   18.175            < 0.001 
     Time         2.162 0.210       - 10.307   < 0.001 
 Condition        -0.593 0.275         - 2.161      0.037 
     
BADS     
     Intercept 53.291 3.344         15.993 < 0.001 
     Time         3.881 0.610 6.364 < 0.001 
Condition         0.667 0.821 0.825    0.414 
     
BADS Activation Subscale     
     Intercept 20.822 1.386 15.021 < 0.001 
     Time 0.612 0.247   2.479    0.017 
Condition 0.825 0.280   2.940    0.005 
 
RPI 
    
     Intercept 47.020 1.130 41.619 < 0.001 
     Time 0.789 0.158   5.007 < 0.001 
Condition 0.458 0.227   2.016    0.050 
 
RPI- Reward Probability  
    
     Intercept 28.597 0.750  38.122 < 0.001 
     Time 0.471 0.082   5.659 < 0.001 
Condition 0.266 0.146   1.814    0.077 
 
RPI- Environmental Suppressors 
    
     Intercept 18.400 0.639 28.806 < 0.001 
     Time 0.322 0.101 3.197    0.003 
     Condition 0.118 0.160 0.736    0.465 
     
     
Note. Random intercept and slope values presented for participants (N=46). Significant 
changes over time highlighted using bolded text. BDI = Beck Depression Inventory; 











Simultaneous Concurrence between Depressive Symptomatology and Proposed 
Moderators of Treatment 
 
Intercept and Fixed Effects    B      SE      t      p-value 
    BADS      
Time -1.152 0.903 -1.277 0.203 
Condition 2.647 2.763 0.958 0.339 
Time x Condition      -0.501 0.614 -0.816 0.415 
Time x BADS                           -0.003 0.011 -0.291 0.771 
         BADS- Activation     
Time -3.298 1.050 -3.140 0.002 
Condition -0.259 2.562 -0.101 0.920 
Time x Condition      0.660 0.663 0.996 0.320 
Time x BADS Activation                          0.064 0.037 1.732 0.084 
         RPI 
    Time -3.508 2.612 -1.343 0.181 
Condition -0.573 2.526 -0.227 0.821 
Time x Condition      0.584 1.346 0.434 0.665 
Time x RPI                         0.023 0.051 0.448 0.665 
         RPI- Reward Probability Index  
    
Time -4.369 2.082 -2.098 0.037 
Condition -0.434 2.595 -0.167 0.867 
Time x Condition      1.096 1.181 0.938 0.354 
Time x RPI Reward Probability Index                      0.065 0.060 1.097 0.273 
         RPI- Environmental Suppressors 
    Time -3.479 1.776 -1.959 0.051 
Condition 0.160 2.542 0.063 0.950 
Time x Condition      0.454 0.970 0.468 0.640 
Time x RPI Environmental Suppressors                      0.105 0.083 1.262 0.208 
 
Note. Random intercept and slope values presented for participants (N=46). Significant 
changes over time highlighted using bolded text. BDI = Beck Depression Inventory; 




 Lagged Relationship between Depressive Symptomatology and Proposed Moderators of 
Treatment 
 
Intercept and Fixed Effects Coefficient SE t p-value 
    
 BADS      
Time -1.675 1.389 -1.206 0.229 
Condition 1.700 3.635 0.468 0.641 
Time x Condition      -0.431 0.788 -0.546 0.586 
Time x BADS                           0.002 0.015 0.097 0.923 
         BADS- Activation     
Time -3.175 1.005 -3.159 0.002 
Condition 0.959 3.622 0.265 0.791 
Time x Condition      0.399 0.651 0.614 0.540 
Time x BADS Activation                          0.049 0.035 1.400 0.163 
         RPI     
Time -5.046 3.887 -1.298 0.196 
Condition -1.037 3.439 -0.302 0.763 
Time x Condition      0.940 1.827 0.514 0.607 
Time x RPI                         0.038 0.074 0.514 0.608 
         RPI- Reward Probability Index  
    Time -5.285 2.517 -2.100 0.037 
Condition -0.573 3.534 -0.162 0.871 
Time x Condition      1.634 1.293 1.263 0.208 
Time x RPI Reward Probability 
Index                      -0.039 0.035 -1.136 0.257 
         RPI- Environmental Suppressors 
    Time -3.632 2.518 -1.442 0.151 
Condition -0.725 3.527 -0.206 0.837 
Time x Condition      0.224 1.180 0.190 0.850 
Time x RPI Environmental 
Suppressors                      0.085 0.109 0.782 0.435 
 
Note. Random intercept and slope values presented for participants (N=46). Significant changes 
over time highlighted using bolded text. BDI = Beck Depression Inventory; BADS = Behavioral 






Changes in Depressive Symptomatology, Activation, and Contact with Environmental 





 Mean (SD) 
1-Month Follow-up    
      Mean (SD) 
    p 
    
BATD (n = 14)    
BDI 10.08 (6.45) 9.58   (8.14) 0.74 
BADS 90.87 (19.34) 87.57 (18.23) 0.16 
BADS-Activation 30.15 (7.00) 30.31  (6.40) 0.48 
RPI 53.14 (7.29) 54.14  (8.11) 0.24 
RPI – Reward Probability 32.07 (5.73) 33.93  (7.13) 0.34 
RPI- Environmental Suppressors 21.39 (3.54) 21.77  (4.00) 0.28 
    
SC (n = 8)    
BDI 14.15 (6.83) 13.50  (9.30) 0.76 
BADS 85.58 (21.03) 90.50 (26.39) 0.45 
BADS-Activation 27.13 (7.81) 24.13 (8.43) 0.88 
RPI 50.00 (6.35) 51.88 (6.33) 0.53 
RPI – Reward Probability 29.38 (4.96) 30.25 (4.77) 0.63 
RPI- Environmental Suppressors 20.63 (3.62) 21.63 (3.78) 0.67 
    
 
Note. Means and standard deviations presented for participants. BDI = Beck Depression 
Inventory; BADS = total Behavioral Activation for Depression Scale; RPI = Reward 















Figure 2. Representation of models that tested the correspondence between increases in 
activation and contact with environmental reinforcement, and decreases in depression. 
Model 1 tested the simultaneous correspondence between depression with activation and 
environmental reinforcement. Model 2 tested if increases in activation and contact with 







Figure 3. Consolidated Standards of Reporting Trials (CONSORT) flowchart of study 
participants, randomization, treatment, follow-ups, and inclusion analyses. BATD: 
Behavioral Activation Treatment for Depression; SC: Supportive Counseling; MDD: 










Figure 4. Depressive symptomatology over time between conditions measured by the 

















































Figure 6. Activity level between conditions over time measured by the BADS Activation 
subscale.  BATD= Behavioral Activation Treatment for Depression; SC= Supportive 


















Figure 7. Environmental reward between conditions over time measured by the RPI total 
scale. BATD= Behavioral Activation Treatment for Depression; SC= Supportive 
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